FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Stanley Fahn

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Living Beings

Procedures

Concepts & Ideas

Pedigree

Co-author Network

Publications

TOP 3
Sheng-Han Kuo; Tao Xie; Stanley Fahn
Anticholinergic responsive cyclic myoclonus.
Rodger J Elble; Stanley Fahn; Mark Hallett; Joseph Jankovic; Jorge L Juncos; Peter LeWitt; Kelly Lyons; William G Ondo; Rajesh Pahwa; Kapil Sethi; Natividad Stover; Daniel Tarsy; Claudia Testa; Ron Tintner; Ray Watts; Cynthia L Comella; Theresa Zesiewicz
Reliability of a new scale for essential tremor.
Mary Ann Thenganatt; Stanley Fahn
Botulinum toxin for the treatment of movement disorders.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Stanley Fahn (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Sheng-Han Kuo; Tao Xie; Stanley Fahn
Anticholinergic responsive cyclic myoclonus.
Movement disorders : official journal of the Movement Disorder Society 2013;28(3):401-2.
2012: Rodger J Elble; Stanley Fahn; Mark Hallett; Joseph Jankovic; Jorge L Juncos; Peter LeWitt; Kelly Lyons; William G Ondo; Rajesh Pahwa; Kapil Sethi; Natividad Stover; Daniel Tarsy; Claudia Testa; Ron Tintner; Ray Watts; Cynthia L Comella; Theresa Zesiewicz
Reliability of a new scale for essential tremor.
Movement disorders : official journal of the Movement Disorder Society 2012;27(12):1567-9.
2012: Mary Ann Thenganatt; Stanley Fahn
Botulinum toxin for the treatment of movement disorders.
Current neurology and neuroscience reports 2012;12(4):399-409.
2012: Matthew J Barrett; Susan B Bressman; Stanley Fahn; Oren A Levy; Michael W O'Dell
Functional electrical stimulation for the treatment of lower extremity dystonia.
Parkinsonism & related disorders 2012;18(5):660-1.
2012: Markos Poulopoulos; Jean-Paul Vonsattel; Cheryl Waters; Lorraine N Clark; Etty Cortes; Lucien J Cote; Stanley Fahn; Lawrence Honig; Karen S Marder; Carol Moskowitz; Roy N Alcalay
Clinical and pathological characteristics of LRRK2 G2019S patients with PD.
Journal of molecular neuroscience : MN 2012;47(1):139-43.
2012: Jian-Fang Ma; Hui-Dong Tang; Dao-Yi Wang; Xiao-Yu Xin; Ying-Jie Zhang; Stanley Fahn; Rong Fang; Liang Liang; Li-Hua Liu; Sheng-Di Chen
Restless legs syndrome in Chinese elderly people of an urban suburb in Shanghai: a community-based survey.
Parkinsonism & related disorders 2012;18(3):294-8.
2012: Andrew J Lees; Federico Micheli; Wolfgang H Oertel; C Warren Olanow; Werner Poewe; Olivier Rascol; David Squillacote; Eduardo Tolosa; M Maral Mouradian; Karla Eggert; Stanley Fahn; Joseph Jankovic; Anthony Lang; Dinesh Kumar
Perampanel, an AMPA antagonist, found to have no benefit in reducing "off" time in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2012;27(2):284-8.
2011: Stanley Fahn
Classification of movement disorders.
Movement disorders : official journal of the Movement Disorder Society 2011;26(6):947-57.
2011: R N Alcalay; A Siderowf; R Ottman; E Caccappolo; H Mejia-Santana; Ming-Xin Tang; L Rosado; E Louis; D Ruiz; C Waters; Stanley Fahn; Lucien J Cote; S Frucht; B Ford; M Orbe-Reilly; B Ross; M Verbitsky; S Kisselev; C Comella; A Colcher; D Jennings; M Nance; Susan Bressman; William Scott; Caroline M Tanner; S Mickel; M Rezak; K E Novak; J H Friedman; Ronald F Pfeiffer; Laura Marsh; B Hiner; L N Clark; K Marder
Olfaction in Parkin heterozygotes and compound heterozygotes: the CORE-PD study.
Neurology 2011;76(4):319-26.
2011: Xinmin Liu; Elan D Louis; Karen Marder; Helen Mejia-Sanatana; Miguel Verbitsky; Cheryl Waters; Howard Andrews; Andrew Browne; Rong Cheng; Lorraine N Clark; Lucien J Cote; Stanley Fahn; Blair Ford; Steven Frucht; Sergey Kisselev; Joseph H Lee
Genome-wide association study identifies candidate genes for Parkinson's disease in an Ashkenazi Jewish population.
BMC medical genetics 2011;12():104.
2011: Elise Caccappolo; Roy N Alcalay; Helen Mejia-Santana; Ming-Xin Tang; Brian Rakitin; Llency Rosado; Elan D Louis; Cynthia L Comella; Amy Colcher; Danna Jennings; Martha A Nance; Susan Bressman; William Scott; Caroline M Tanner; Susan F Mickel; Howard F Andrews; Cheryl Waters; Stanley Fahn; Lucien J Cote; Steven Frucht; Blair Ford; Michael Rezak; Kevin Novak; Joseph H Friedman; Ronald F Pfeiffer; Laura Marsh; Brad Hiner; Andrew D Siderowf; Barbara M Ross; Miguel Verbitsky; Sergey Kisselev; Ruth Ottman; Lorraine N Clark; Karen S Marder
Neuropsychological Profile of Parkin Mutation Carriers with and without Parkinson Disease: The CORE-PD Study.
Journal of the International Neuropsychological Society : JINS 2011;17(1):91-100.
2010: Steven R Schwid; Janice Bausch; David Oakes; Lynn Schuchter; Caroline M Tanner; Misser Forrest; Anthony E Lang; Ira Shoulson; Ira Shoulson; Christopher Hyson; David Oakes; Emily Flagg; Alice Rudolph; Karl Kieburtz; Anthony Lang; Stanley Fahn; Lisa Gauger; Christopher Goetz
Cancer incidence in a trial of an antiapoptotic agent for Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2010;25(12):1801-8.
2010: Rebecca M Wolf Gilbert; Stanley Fahn; Hiroshi Mitsumoto; Lewis P Rowland
Parkinsonism and motor neuron diseases: twenty-seven patients with diverse overlap syndromes.
Movement disorders : official journal of the Movement Disorder Society 2010;25(12):1868-75.
2010: Roy N Alcalay; Elise Caccappolo; Helen Mejia-Santana; Ming-Xin Tang; Llency Rosado; Barbara M Ross; Miguel Verbitsky; Sergey Kisselev; Elan D Louis; Cynthia Comella; Amy Colcher; Danna Jennings; Martha A Nance; Susan Bressman; William Scott; Caroline M Tanner; Susan Mickel; Howard Andrews; Cheryl Waters; Stanley Fahn; Lucien J Cote; Steven Frucht; Blair Ford; Michael Rezak; Kevin Novak; Joseph H Friedman; Ronald F Pfeiffer; Laura Marsh; Bradley Hiner; Andrew Siderowf; Ruth Ottman; Karen Marder; Lorraine N Clark
Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study.
Archives of neurology 2010;67(9):1116-22.
2010: Roy N Alcalay; Helen Mejia-Santana; Ming-Xin Tang; Brian Rakitin; Llency Rosado; Barbara Ross; Miguel Verbitsky; Sergey Kisselev; Elan D Louis; Cynthia L Comella; Amy Colcher; Danna Jennings; Martha A Nance; Susan Bressman; William Scott; Caroline M Tanner; Susan F Mickel; Howard F Andrews; Cheryl H Waters; Stanley Fahn; Lucien J Cote; Steven J Frucht; Blair Ford; Michael Rezak; Kevin Novak; Joseph H Friedman; Ronald F Pfeiffer; Laura Marsh; Bradley Hiner; Andrew Siderowf; Ruth Ottman; Lorraine N Clark; Karen S Marder; Elise Caccappolo
Self-report of cognitive impairment and mini-mental state examination performance in PRKN, LRRK2, and GBA carriers with early onset Parkinson's disease.
Journal of clinical and experimental neuropsychology 2010;32(7):775-9.
2010: Christopher G Goetz; Glenn T Stebbins; Teresa Chmura; Stanley Fahn; Werner Poewe; Caroline M Tanner
Teaching program for the Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale: (MDS-UPDRS).
Movement disorders : official journal of the Movement Disorder Society 2010;25(9):1190-4.
2010: Karen S Marder; Ming-Xin Tang; Helen Mejia-Santana; Llency Rosado; Elan D Louis; Cynthia L Comella; Amy Colcher; Andrew D Siderowf; Danna Jennings; Martha A Nance; Susan Bressman; William Scott; Caroline M Tanner; Susan F Mickel; Howard F Andrews; Cheryl Waters; Stanley Fahn; Barbara M Ross; Lucien J Cote; Steven Frucht; Blair Ford; Roy N Alcalay; Michael Rezak; Kevin Novak; Joseph H Friedman; Ronald F Pfeiffer; Laura Marsh; Brad Hiner; Gregory D Neils; Miguel Verbitsky; Sergey Kisselev; Elise Caccappolo; Ruth Ottman; Lorraine N Clark
Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study.
Archives of neurology 2010;67(6):731-8.
2010: Chris C Tang; Kathleen L Poston; Thomas Eckert; Andrew Feigin; Steven Frucht; Mark Gudesblatt; Vijay Dhawan; Martin Lesser; Jean-Paul Vonsattel; Stanley Fahn; David Eidelberg
Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis.
Lancet neurology 2010;9(2):149-58.
2010: Stanley Fahn
Parkinson's disease: 10 years of progress, 1997-2007.
Movement disorders : official journal of the Movement Disorder Society 2010;25 Suppl 1():S2-14.
2010: Stanley Fahn; Karen Marder; Lucien J Cote
Frontiers of science and clinical advances in quality of life in Parkinson's disease. Preface.
Movement disorders : official journal of the Movement Disorder Society 2010;25 Suppl 1():S1.
2010: Yilong Ma; Chengke Tang; Thomas Chaly; Paul Greene; Robert Breeze; Stanley Fahn; Curt Freed; Vijay Dhawan; David Eidelberg
Dopamine cell implantation in Parkinson's disease: long-term clinical and (18)F-FDOPA PET outcomes.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2010;51(1):7-15.
2009: Connie Marras; Anthony E Lang; Shirley W Eberly; David Oakes; Stanley Fahn; Steven R Schwid; Christopher Hyson; Ira Shoulson
A comparison of treatment thresholds in two large Parkinson's disease clinical trial cohorts.
Movement disorders : official journal of the Movement Disorder Society 2009;24(16):2370-8.
2009: Roy N Alcalay; Helen Mejia-Santana; Ming-Xin Tang; Llency Rosado; Miguel Verbitsky; Sergey Kisselev; Barbara M Ross; Elan D Louis; Cynthia L Comella; Amy Colcher; Danna Jennings; Martha A Nance; Susan Bressman; William Scott; Caroline M Tanner; Susan F Mickel; Howard F Andrews; Cheryl H Waters; Stanley Fahn; Lucien J Cote; Steven J Frucht; Blair Ford; Michael Rezak; Kevin Novak; Joseph H Friedman; Ronald F Pfeiffer; Laura Marsh; Bradley Hiner; Andrew Siderowf; Elise Caccappolo; Ruth Ottman; Lorraine N Clark; Karen S Marder
Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson disease.
Archives of neurology 2009;66(12):1517-22.
2009: Alberto Ascherio; Peter LeWitt; Kui Xu; Shirley Eberly; Arthur Watts; Wayne R Matson; Connie Marras; Karl Kieburtz; Alice Rudolph; Mikhail B Bogdanov; Steven R Schwid; Marsha Tennis; Caroline M Tanner; M Flint Beal; Anthony E Lang; David Oakes; Stanley Fahn; Ira Shoulson; Michael A Schwarzschild
Urate as a predictor of the rate of clinical decline in Parkinson disease.
Archives of neurology 2009;66(12):1460-8.
2009: Bernard Ravina; Caroline M Tanner; Diane Dieuliis; Shirley Eberly; Emily Flagg; Wendy R Galpern; Stanley Fahn; Christopher G Goetz; Stephen Grate; Roger Kurlan; Anthony E Lang; Kenneth Marek; Karl Kieburtz; David Oakes; Robin Elliott; Ira Shoulson
A longitudinal program for biomarker development in Parkinson's disease: a feasibility study.
Movement disorders : official journal of the Movement Disorder Society 2009;24(14):2081-90.
2009: E Sidransky; M A Nalls; J O Aasly; J Aharon-Peretz; G Annesi; E R Barbosa; A Bar-Shira; D Berg; J Bras; A Brice; C-M Chen; L N Clark; C Condroyer; Elvira De Marco; A Dürr; M J Eblan; Stanley Fahn; M J Farrer; H-C Fung; Ziv Gan-Or; T Gasser; R Gershoni-Baruch; N Giladi; A Griffith; T Gurevich; C Januario; P Kropp; A E Lang; G-J Lee-Chen; S Lesage; K Marder; I F Mata; A Mirelman; Jun Mitsui; I Mizuta; G Nicoletti; C Oliveira; R Ottman; A Orr-Urtreger; Lygia Pereira; A Quattrone; E Rogaeva; A Rolfs; H Rosenbaum; R Rozenberg; A Samii; T Samaddar; C Schulte; M Sharma; Andrew Singleton; M Spitz; E-K Tan; N Tayebi; T Toda; A R Troiano; S Tsuji; M Wittstock; T G Wolfsberg; Y-R Wu; Cyrus Zabetian; Y Zhao; S G Ziegler
Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease.
The New England journal of medicine 2009;361(17):1651-61.
2009: Lorraine N Clark; Lykourgos A Kartsaklis; Rebecca Wolf Gilbert; Beatriz Dorado; Barbara M Ross; Sergey Kisselev; Miguel Verbitsky; Helen Mejia-Santana; Lucien J Cote; Howard Andrews; Jean-Paul Vonsattel; Stanley Fahn; Richard Mayeux; Lawrence Honig; Karen Marder
Association of glucocerebrosidase mutations with dementia with lewy bodies.
Archives of neurology 2009;66(5):578-83.
2009: Anthony E Lang; Michael Angel; Kailash Bhatia; Robert Chen; Stanley Fahn; Mark Hallett; Anette Schrag; Philip Thompson
Myoclonus in complex regional pain syndrome.
Movement disorders : official journal of the Movement Disorder Society 2009;24(2):314-6; author reply 316.
2008: Stanley Fahn
How do you treat motor complications in Parkinson's disease: Medicine, surgery, or both?
Annals of neurology 2008;64 Suppl 2():S56-64.
2008: Christopher G Goetz; Barbara C Tilley; Stephanie R Shaftman; Glenn T Stebbins; Stanley Fahn; Pablo Martinez-Martin; Werner Poewe; Cristina Sampaio; Matthew B Stern; Richard Dodel; Bruno Dubois; Robert Holloway; Joseph Jankovic; Jaime Kulisevsky; Anthony E Lang; Andrew J Lees; Sue Leurgans; Peter LeWitt; David L Nyenhuis; C Warren Olanow; Olivier Rascol; Anette Schrag; Jeanne A Teresi; Jacobus J van Hilten; Nancy LaPelle
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.
Movement disorders : official journal of the Movement Disorder Society 2008;23(15):2129-70.
2008: Giovanni Schifitto; Joseph H Friedman; David Oakes; Lisa M Shulman; C L Comella; Kenneth Marek; Stanley Fahn
Fatigue in levodopa-naive subjects with Parkinson disease.
Neurology 2008;71(7):481-5.
2008: Michael A Schwarzschild; Steven R Schwid; Kenneth Marek; Arthur Watts; Anthony E Lang; David Oakes; Ira Shoulson; Alberto Ascherio; Christopher Hyson; Emily Gorbold; Alice Rudolph; Karl Kieburtz; Stanley Fahn; Lisa Gauger; Christopher G Goetz; John P Seibyl; Misser Forrest; John Ondrasik
Serum urate as a predictor of clinical and radiographic progression in Parkinson disease.
Archives of neurology 2008;65(6):716-23.
2008: Samuel Frank; William G Ondo; Stanley Fahn; Christine Hunter; David Oakes; Sandra Plumb; Frederick John Marshall; Ira Shoulson; Shirley Eberly; Francis Walker; Stewart A Factor; Vicki Hunt; Aileen Shinaman; Joseph Jankovic
A study of chorea after tetrabenazine withdrawal in patients with Huntington disease.
Clinical neuropharmacology 2008;31(3):127-33.
2008: Christopher G Goetz; Joanne Wuu; Michael P McDermott; Charles H Adler; Stanley Fahn; Curt R Freed; Robert A Hauser; Warren C Olanow; Ira Shoulson; P K Tandon; Sue Leurgans
Placebo response in Parkinson's disease: comparisons among 11 trials covering medical and surgical interventions.
Movement disorders : official journal of the Movement Disorder Society 2008;23(5):690-9.
2008: Yuanjia Wang; Lorraine N Clark; Elan D Louis; Helen Mejia-Santana; Juliette Harris; Lucien J Cote; Cheryl Waters; Howard Andrews; Blair Ford; Steven Frucht; Stanley Fahn; Ruth Ottman; daniel rabinowitz; Karen Marder
Risk of Parkinson disease in carriers of parkin mutations: estimation using the kin-cohort method.
Archives of neurology 2008;65(4):467-74.
2008: Stanley Fahn
The history of dopamine and levodopa in the treatment of Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2008;23 Suppl 3():S497-508.
2007: Shearwood McClelland; Jean-Paul Vonsattel; R E Garcia; M D Amaya; Linda M Winfield; Seth L Pullman; Qiping Yu; Stanley Fahn; Blair Ford; Robert R Goodman
Relationship of clinical efficacy to postmortem-determined anatomic subthalamic stimulation in Parkinson syndrome.
Clinical neuropathology 2007;26(6):267-75.
2007: Lorraine N Clark; B M Ross; Yuanjia Wang; Helen Mejia-Santana; Juliette Harris; Elan D Louis; Lucien J Cote; Howard Andrews; Stanley Fahn; Cheryl Waters; Blair Ford; Steven Frucht; Ruth Ottman; Karen Marder
Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease.
Neurology 2007;69(12):1270-7.
2007: Yanush Sanotsky; Roman Lesyk; Lyudmyla Fedoryshyn; Iryna Komnatska; Yuriy Matviyenko; Stanley Fahn
Manganic encephalopathy due to "ephedrone" abuse.
Movement disorders : official journal of the Movement Disorder Society 2007;22(9):1337-43.
2007: Lorraine N Clark; Eneli Haamer; Helen Mejia-Santana; Juliette Harris; Suzanne Lesage; Alexandra Durr; Sabine Janin Bs; Katja Hedrich; Elan D Louis; Lucien J Cote; Howard Andrews; Stanley Fahn; Cheryl Waters; Blair Ford; Steven Frucht; William Scott; Christine Klein; Alexis Brice; Hanno Roomere; Ruth Ottman; Karen Marder
Construction and validation of a Parkinson's disease mutation genotyping array for the Parkin gene.
Movement disorders : official journal of the Movement Disorder Society 2007;22(7):932-7.
2007: Carol F Lippa; J E Duda; Murray Grossman; Howard I Hurtig; Dag Aarsland; Bradley Boeve; David J Brooks; dennis dickson; Bruno Dubois; M Emre; Stanley Fahn; J M Farmer; Douglas Galasko; James E Galvin; Christopher G Goetz; John H Growdon; Katrina Gwinn-Hardy; John Hardy; Peter Heutink; Takeshi Iwatsubo; K Kosaka; Virginia M-Y Lee; James B Leverenz; Eliezer Masliah; Ian G McKeith; Robert L Nussbaum; C Warren Olanow; B M Ravina; Andrew Singleton; Caroline M Tanner; John Q Trojanowski; Zbigniew K Wszolek
DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers.
Neurology 2007;68(11):812-9.
2007: Melissa J Nirenberg; Jenny Libien; Jean-Paul Vonsattel; Stanley Fahn
Multiple system atrophy in a patient with the spinocerebellar ataxia 3 gene mutation.
Movement disorders : official journal of the Movement Disorder Society 2007;22(2):251-4.
2007: Christopher G Goetz; Stanley Fahn; Pablo Martinez-Martin; Werner Poewe; Cristina Sampaio; Glenn T Stebbins; Matthew B Stern; Barbara C Tilley; Richard Dodel; Bruno Dubois; Robert Holloway; Joseph Jankovic; Jaime Kulisevsky; Anthony E Lang; Andrew J Lees; Sue Leurgans; Peter LeWitt; David L Nyenhuis; C Warren Olanow; Olivier Rascol; Anette Schrag; Jeanne A Teresi; Jacobus J van Hilten; Nancy Lapelle
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan.
Movement disorders : official journal of the Movement Disorder Society 2007;22(1):41-7.
2006: Lorraine N Clark; Yuanjia Wang; Eric Karlins; L Saito; Helen Mejia-Santana; Juliette Harris; Elan D Louis; Lucien J Cote; Howard Andrews; Stanley Fahn; Cheryl Waters; Blair Ford; Steven Frucht; Ruth Ottman; Karen Marder
Frequency of LRRK2 mutations in early- and late-onset Parkinson disease.
Neurology 2006;67(10):1786-91.
2006: L Elmer; Steven R Schwid; Shirley Eberly; Christopher G Goetz; Stanley Fahn; Karl Kieburtz; David Oakes; Karen Blindauer; P Salzman; S Oren; U L Prisco; Matthew B Stern; Ira Shoulson
Rasagiline-associated motor improvement in PD occurs without worsening of cognitive and behavioral symptoms.
Journal of the neurological sciences 2006;248(1-2):78-83.
2006: J Antonelle deMarcaida; Steven R Schwid; William B White; Karen Blindauer; Stanley Fahn; Karl Kieburtz; Matthew B Stern; Ira Shoulson
Effects of tyramine administration in Parkinson's disease patients treated with selective MAO-B inhibitor rasagiline.
Movement disorders : official journal of the Movement Disorder Society 2006;21(10):1716-21.
2006: Kevin M Biglan; Steven R Schwid; Shirley Eberly; Karen Blindauer; Stanley Fahn; Tamar Goren; Karl Kieburtz; David Oakes; Sandra Plumb; Andrew Siderowf; Matthew B Stern; Ira Shoulson
Rasagiline improves quality of life in patients with early Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2006;21(5):616-23.
2006: Lorraine N Clark; Shehla Afridi; Eric Karlins; Yuanjia Wang; Helen Mejia-Santana; Juliette Harris; Elan D Louis; Lucien J Cote; Howard Andrews; Stanley Fahn; Cheryl Waters; Blair Ford; Steven Frucht; Ruth Ottman; Karen Marder
Case-control study of the parkin gene in early-onset Parkinson disease.
Archives of neurology 2006;63(4):548-52.
2006: Carlos Portera-Cailliau; Daryl Victor; Steven Frucht; Stanley Fahn
Movement disorders fellowship training program at Columbia University Medical Center in 2001-2002.
Movement disorders : official journal of the Movement Disorder Society 2006;21(4):479-85.
2006: Karen Blindauer; Ira Shoulson; David Oakes; Karl Kieburtz; Steven R Schwid; Stanley Fahn; Matthew B Stern; Christopher G Goetz; John G Nutt; Sari Goren; Naim Sayag; Marisa Scolnik; Ruth Levy; Eli Eyal; Phyllis Salzman; Mary Pagano
A randomized controlled trial of etilevodopa in patients with Parkinson disease who have motor fluctuations.
Archives of neurology 2006;63(2):210-6.
2006: Stanley Fahn
Levodopa in the treatment of Parkinson's disease.
Journal of neural transmission. Supplementum 2006;(71):1-15.
2006: Stanley Fahn
A new look at levodopa based on the ELLDOPA study.
Journal of neural transmission. Supplementum 2006;(70):419-26.
2005: Stanley Fahn
Does levodopa slow or hasten the rate of progression of Parkinson's disease?
Journal of neurology 2005;252 Suppl 4():IV37-IV42.
2005: Connie Marras; Anthony E Lang; David Oakes; Michael P McDermott; Karl Kieburtz; Ira Shoulson; Caroline M Tanner; Stanley Fahn
High-dosage vitamin E supplementation and all-cause mortality.
Annals of internal medicine 2005;143(2):152-3; author reply 156-8.
2005: Gilberto Levy; Elan D Louis; Lucien J Cote; Mario Perez; Helen Mejia-Santana; Howard Andrews; Juliette Harris; Cheryl Waters; Blair Ford; Steven Frucht; Stanley Fahn; Karen Marder
Contribution of aging to the severity of different motor signs in Parkinson disease.
Archives of neurology 2005;62(3):467-72.
2005: B Ravina; David Eidelberg; J Eric Ahlskog; Roger L Albin; David J Brooks; M Carbon; Vijay Dhawan; A Feigin; Stanley Fahn; M Guttman; Katrina Gwinn-Hardy; Henry McFarland; Robert B Innis; R G Katz; Karl Kieburtz; Stephen J Kish; N Lange; J William Langston; Kenneth Marek; L Morin; C Moy; D Murphy; Wolfgang H Oertel; G Oliver; Yuko Y Palesch; W Powers; John P Seibyl; Kapil D Sethi; Clifford W Shults; P Sheehy; A Jon Stoessl; R Holloway
The role of radiotracer imaging in Parkinson disease.
Neurology 2005;64(2):208-15.
2005: Daniel T Williams; Blair Ford; Stanley Fahn
Treatment issues in psychogenic-neuropsychiatric movement disorders.
Advances in neurology 2005;96():350-63.
2005: Lorraine N Clark; Angelique Nicolai; Shehla Afridi; Juliette Harris; Helen Mejia-Santana; Lisa J Strug; Lucien J Cote; Elan D Louis; Howard Andrews; Cheryl Waters; Blair Ford; Steven Frucht; Stanley Fahn; Richard Mayeux; Ruth Ottman; Karen Marder
Pilot association study of the beta-glucocerebrosidase N370S allele and Parkinson's disease in subjects of Jewish ethnicity.
Movement disorders : official journal of the Movement Disorder Society 2005;20(1):100-3.
2004: Stanley Fahn; David Oakes; Ira Shoulson; Karl Kieburtz; Alice Rudolph; Anthony E Lang; C Warren Olanow; Caroline M Tanner; Kenneth Marek
Levodopa and the progression of Parkinson's disease.
The New England journal of medicine 2004;351(24):2498-508.
2004: Russell L Margolis; Susan E Holmes; Adam Rosenblatt; Lisa M Gourley; Elizabeth O'Hearn; Christopher A Ross; William K Seltzer; Ruth H Walker; Tetsuo Ashizawa; Astrid Rasmussen; Michael R Hayden; Elisabeth W Almqvist; Juliette Harris; Stanley Fahn; Marcy E MacDonald; Jayalakshmi Mysore; Takayoshi Shimohata; Shoji Tsuji; Nicholas T Potter; Kazuhiro Nakaso; Yoshiki Adachi; Kenji Nakashima; Thomas D Bird; Amanda Krause; Penny Greenstein
Huntington's Disease-like 2 (HDL2) in North America and Japan.
Annals of neurology 2004;56(5):670-4.
2004: Stanley Fahn
ALS lessons learned from other neurological diseases. Parkinson's disease.
Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases 2004;5 Suppl 1():26-30.
2004: Blair Ford; Linda M Winfield; Seth L Pullman; Steven Frucht; Y Du; Paul Greene; J H Cheringal; Qiping Yu; Lucien J Cote; Stanley Fahn; G M McKhann; Robert R Goodman
Subthalamic nucleus stimulation in advanced Parkinson's disease: blinded assessments at one year follow up.
Journal of neurology, neurosurgery, and psychiatry 2004;75(9):1255-9.
2004: Paul H Gordon; Stanley Fahn; Steven Chin; Lawrence I Golbe; Timothy Lynch; David Eidelberg
Woman with a 26-year history of parkinsonism, supranuclear ophthalmoplegia, and loss of postural reflexes.
Movement disorders : official journal of the Movement Disorder Society 2004;19(8):950-61.
2004: Robert G Holloway; Ira Shoulson; Stanley Fahn; Karl Kieburtz; Anthony E Lang; Kenneth Marek; Michael McDermott; John P Seibyl; William J Weiner; Bruno Musch; Cornelia Kamp; Mickie Welsh; Aileen Shinaman; Rajesh Pahwa; Lynn Barclay; Jean P Hubble; Peter LeWitt; Janis Miyasaki; Oksana Suchowersky; Mark Stacy; David S Russell; Blair Ford; John P Hammerstad; David Riley; David Standaert; Frederick Wooten; Stewart A Factor; Joseph Jankovic; Farah Atassi; Roger Kurlan; Michel Panisset; Ali H Rajput; Robert Rodnitzky; Clifford W Shults; Giselle Petsinger; Cheryl Waters; Ronald F Pfeiffer; Kevin Biglan; Leona Borchert; Amy Montgomery; Laura Sutherland; Carolyn Weeks; Maryan DeAngelis; Elspeth Sime; Susan Wood; Carol Pantella; Mary Harrigan; Barbara Fussell; Sandra Dillon; Barbara Alexander-Brown; Pamela Rainey; Marsha Tennis; Elke Rost-Ruffner; Diane Brown; Sharon Evans; Debra Berry; Jean Hall; Theresa Shirley; Judith Dobson; Deborah Fontaine; Brenda Pfeiffer; Alicia Brocht; Susan Bennett; Susan Daigneault; Karen Hodgeman; Carolynn O'Connell; Tori Ross; Karen Richard; Arthur Watts
Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.
Archives of neurology 2004;61(7):1044-53.
2004: Gilberto Levy; Elan D Louis; Helen Mejia-Santana; Lucien J Cote; Howard Andrews; Juliette Harris; Cheryl Waters; Blair Ford; Steven Frucht; Stanley Fahn; Ruth Ottman; Karen Marder
Lack of familial aggregation of Parkinson disease and Alzheimer disease.
Archives of neurology 2004;61(7):1033-9.
2004: Lorraine N Clark; Shehla Afridi; Helen Mejia-Santana; Juliette Harris; Elan D Louis; Lucien J Cote; Howard Andrews; Andrew Singleton; Fabienne Wavrant De-Vrieze; John Hardy; Richard Mayeux; Stanley Fahn; Cheryl Waters; Blair Ford; Steven Frucht; Ruth Ottman; Karen Marder
Analysis of an early-onset Parkinson's disease cohort for DJ-1 mutations.
Movement disorders : official journal of the Movement Disorder Society 2004;19(7):796-800.
2004: Paul H Gordon; Qiping Yu; Clifford Qualls; Hal Winfield; Sandra Dillon; Paul Greene; Stanley Fahn; Robert E Breeze; Curt R Freed; Seth L Pullman
Reaction time and movement time after embryonic cell implantation in Parkinson disease.
Archives of neurology 2004;61(6):858-61.
2004: Pinky Agarwal; Stanley Fahn; Steven J Frucht
Diagnosis and management of pergolide-induced fibrosis.
Movement disorders : official journal of the Movement Disorder Society 2004;19(6):699-704.
2004: Curt R Freed; Robert E Breeze; Stanley Fahn; David Eidelberg
Preoperative response to levodopa is the best predictor of transplant outcome.
Annals of neurology 2004;55(6):896; author reply 896-7.
2004: Cynthia McRae; Eva Cherin; T Gayle Yamazaki; Gretchen Diem; Alexander Vo; Dan Russell; J Heiner Ellgring; Stanley Fahn; Paul Greene; Sandra Dillon; Hal Winfield; Kimberly B Bjugstad; Curt R Freed
Effects of perceived treatment on quality of life and medical outcomes in a double-blind placebo surgery trial.
Archives of general psychiatry 2004;61(4):412-20.
2004: Renato P Munhoz; J-Y Li; M Kurtinecz; Panida Piboolnurak; A Constantino; Stanley Fahn; Anthony E Lang
Evaluation of the pull test technique in assessing postural instability in Parkinson's disease.
Neurology 2004;62(1):125-7.
2004: Stanley Fahn; David Sulzer
Neurodegeneration and neuroprotection in Parkinson disease.
NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics 2004;1(1):139-54.
2004: Stanley Fahn
Deep-brain stimulation extends relief from Parkinson's. Electrodes deep in the brain continue relieving Parkinson's disease symptoms for five years.
Health news (Waltham, Mass.) 2004;10(1):6-7.
2004: Yoshiaki Furukawa; Stephen J Kish; Stanley Fahn
Dopa-responsive dystonia due to mild tyrosine hydroxylase deficiency.
Annals of neurology 2004;55(1):147-8.
2003: Roger Rosenberg; Timothy A Pedley; J Richard Baringer; Stanley Fahn; Robert P Lisak; Richard Mayeux; Sandra F Olson; Steven P Ringel; Lewis P Rowland; Michael E Selzer
At jeopardy: the NIH as we know it.
Neurorehabilitation and neural repair 2003;17(4):203-5.
2003: Oren Cohen; Stanley Fahn; Steven J Frucht
Severe cervical dystonia in pathologically proven Parkinson's disease and dementia.
Movement disorders : official journal of the Movement Disorder Society 2003;18(11):1381-2.
2003: Elan D Louis; Gilberto Levy; Helen Mejia-Santana; Lucien J Cote; Howard Andrews; Juliette Harris; Cheryl Waters; Blair Ford; Steven Frucht; Stanley Fahn; Ruth Ottman; Karen Marder
Risk of action tremor in relatives of tremor-dominant and postural instability gait disorder PD.
Neurology 2003;61(7):931-6.
2003: Karen Marder; Gilberto Levy; Elan D Louis; Helen Mejia-Santana; Lucien J Cote; Howard Andrews; Juliette Harris; Cheryl Waters; Blair Ford; Steven Frucht; Stanley Fahn; Ruth Ottman
Familial aggregation of early- and late-onset Parkinson's disease.
Annals of neurology 2003;54(4):507-13.
2003: Roger Rosenberg; Timothy A Pedley; J Richard Baringer; Stanley Fahn; Robert P Lisak; Richard Mayeux; Sandra F Olson; Steven P Ringel; Lewis P Rowland; Michael E Selzer
At jeopardy: the NIH as we know it.
Archives of neurology 2003;60(9):1191-2.
2003: Karen Marder; Gilberto Levy; Elan D Louis; Helen Mejia-Santana; Lucien J Cote; Howard Andrews; Juliette Harris; Cheryl Waters; Blair Ford; Steven Frucht; Stanley Fahn; Ruth Ottman
Accuracy of family history data on Parkinson's disease.
Neurology 2003;61(1):18-23.
2003: C T Trott; Stanley Fahn; Paul Greene; Sandra Dillon; Hal Winfield; Linda M Winfield; R Kao; David Eidelberg; Curt R Freed; Robert E Breeze; Yaakov Stern
Cognition following bilateral implants of embryonic dopamine neurons in PD: a double blind study.
Neurology 2003;60(12):1938-43.
2003: Stanley Fahn
Description of Parkinson's disease as a clinical syndrome.
Annals of the New York Academy of Sciences 2003;991():1-14.
2003: Cynthia McRae; Eva Cherin; Gretchen Diem; Alexander Vo; J Heiner Ellgring; Dan Russell; Stanley Fahn; Curt R Freed
Does personality change as a result of fetal tissue transplantation in the brain?
Journal of neurology 2003;250(3):282-6.
2003: Kelly E Lyons; Rajesh Pahwa; Cynthia L Comella; Mahmood S Eisa; Rodger J Elble; Stanley Fahn; Joseph Jankovic; Jorge L Juncos; William Koller; William G Ondo; Kapil D Sethi; Matthew B Stern; Caroline M Tanner; Ron Tintner; Ray L Watts
Benefits and risks of pharmacological treatments for essential tremor.
Drug safety : an international journal of medical toxicology and drug experience 2003;26(7):461-81.
2002: Susan Bressman; Deborah Raymond; K Wendt; Rachel Saunders-Pullman; Deborah de Leon; Stanley Fahn; Laurie J Ozelius; Neil Risch
Diagnostic criteria for dystonia in DYT1 families.
Neurology 2002;59(11):1780-2.
2002: P H Gordon; Seth L Pullman; Elan D Louis; Steven Frucht; Stanley Fahn
Mirtazapine in Parkinsonian tremor.
Parkinsonism & related disorders 2002;9(2):125-6.
2002: Paul Greene; Stanley Fahn
Status of fetal tissue transplantation for the treatment of advanced Parkinson disease.
Neurosurgical focus 2002;13(5):e3.
2002: Yilong Ma; Andrew Feigin; Vijay Dhawan; Masafumi Fukuda; Qiuhu Shi; Paul Greene; Robert E Breeze; Stanley Fahn; Curt R Freed; David Eidelberg
Dyskinesia after fetal cell transplantation for parkinsonism: a PET study.
Annals of neurology 2002;52(5):628-34.
2002: Norman Kock; Birgitt Müller; Peter Vieregge; Peter P Pramstaller; Karen Marder; Giovanni Abbruzzese; Paolo Martinelli; Anthony E Lang; Helfried Jacobs; Johann Hagenah; Juliette Harris; Helen Meija-Santana; Stanley Fahn; Katja Hedrich; Martin Kann; Ulrike Gehlken; Biljana Culjkovic; Eberhard Schwinger; Zbigniew K Wszolek; Christine Zühlke; Christine Klein
Role of SCA2 mutations in early- and late-onset dopa-responsive parkinsonism.
Annals of neurology 2002;52(2):257-8; author reply 258.
2002: Elan D Louis; Gilberto Levy; Lucien J Côte; Helen Mejia; Stanley Fahn; Karen Marder
Diagnosing Parkinson's disease using videotaped neurological examinations: validity and factors that contribute to incorrect diagnoses.
Movement disorders : official journal of the Movement Disorder Society 2002;17(3):513-7.
2002: Ira Shoulson; David Oakes; Stanley Fahn; Anthony E Lang; J William Langston; Peter LeWitt; C Warren Olanow; John B Penney; Caroline M Tanner; Karl Kieburtz; Alice Rudolph
Impact of sustained deprenyl (selegiline) in levodopa-treated Parkinson's disease: a randomized placebo-controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trial.
Annals of neurology 2002;51(5):604-12.
2002: Katja Hedrich; Karen Marder; Juliette Harris; Martin Kann; T Lynch; Helen Meija-Santana; Peter P Pramstaller; Eberhard Schwinger; Susan Bressman; Stanley Fahn; Christine Klein
Evaluation of 50 probands with early-onset Parkinson's disease for Parkin mutations.
Neurology 2002;58(8):1239-46.
2002: Timothy A Pedley; Thomas R Swift; Aaron Miller; Stanley Fahn
Pharmaceutical industry support of the AAN Annual Meeting: policies and violation.
Neurology 2002;58(4):519-21.
2002: Anjan Chatterjee; Stanley Fahn
Methylphenidate treats apathy in Parkinson's disease.
The Journal of neuropsychiatry and clinical neurosciences 2002;14(4):461-2.
2002: Stanley Fahn
The early history of paroxysmal dyskinesias.
Advances in neurology 2002;89():377-85.
2002: Steven Frucht; Sue Leurgans; Mark Hallett; Stanley Fahn
The Unified Myoclonus Rating Scale.
Advances in neurology 2002;89():361-76.
2002: Stanley Fahn
Overview, history, and classification of myoclonus.
Advances in neurology 2002;89():13-7.
2002: Cathy Chuang; Stanley Fahn; Steven Frucht
The natural history and treatment of acquired hemidystonia: report of 33 cases and review of the literature.
Journal of neurology, neurosurgery, and psychiatry 2002;72(1):59-67.
2001: T Lynch; Mary Sano; Karen Marder; Karen L Bell; Norman L Foster; R F Defendini; Anders A F Sima; C Keohane; TG Nygaard; Stanley Fahn; Richard Mayeux; Lewis P Rowland; Kirk Wilhelmsen
Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy complex. 1994.
Neurology 2001;57(10 Suppl 3):S39-45.
2001: Elan D Louis; Gilberto Levy; L J Côte; Helen Mejia; Stanley Fahn; Karen Marder
Clinical correlates of action tremor in Parkinson disease.
Archives of neurology 2001;58(10):1630-4.
2001: Steven Frucht; Elan D Louis; Cathy Chuang; Stanley Fahn
A pilot tolerability and efficacy study of levetiracetam in patients with chronic myoclonus.
Neurology 2001;57(6):1112-4.
2001: Steven Frucht; Stanley Fahn; P E Greene; C O'Brien; M Gelb; D D Truong; J Welsh; Stewart A Factor; B Ford
The natural history of embouchure dystonia.
Movement disorders : official journal of the Movement Disorder Society 2001;16(5):899-906.
2001: T Nakamura; Vijay Dhawan; Thomas Chaly; M Fukuda; Yilong Ma; Robert E Breeze; Paul Greene; Stanley Fahn; Curt R Freed; David Eidelberg
Blinded positron emission tomography study of dopamine cell implantation for Parkinson's disease.
Annals of neurology 2001;50(2):181-7.
2001: Nir Giladi; M P McDermott; Stanley Fahn; Serge Przedborski; Joseph Jankovic; Matthew B Stern; Caroline M Tanner
Freezing of gait in PD: prospective assessment in the DATATOP cohort.
Neurology 2001;56(12):1712-21.
2001: Elan D Louis; Linda M Winfield; Stanley Fahn; Blair Ford
Speech dysfluency exacerbated by levodopa in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2001;16(3):562-5.
2001: Susan Bressman; Stanley Fahn; Laurie J Ozelius; Patricia L Kramer; Neil J Risch
The DYT1 mutation and nonfamilial primary torsion dystonia.
Archives of neurology 2001;58(4):681-2.
2001: Curt R Freed; Paul Greene; Robert E Breeze; W Y Tsai; W DuMouchel; R Kao; Sandra Dillon; Hal Winfield; S Culver; John Q Trojanowski; David Eidelberg; Stanley Fahn
Transplantation of embryonic dopamine neurons for severe Parkinson's disease.
The New England journal of medicine 2001;344(10):710-9.
2001: Ira Shoulson; J Penney; M McDermott; S Schwid; E Kayson; Thomas N Chase; Stanley Fahn; J Timothy Greenamyre; Anthony E Lang; A Siderowf; N Pearson; M Harrison; E Rost; A Colcher; M Lloyd; M Matthews; Rajesh Pahwa; D McGuire; M F Lew; S Schuman; Kenneth Marek; S Broshjeit; Stewart A Factor; D Brown; A Feigin; J Mazurkiewicz; B Ford; D Jennings; S Dilllon; C Comella; L Blasucci; K Janko; Lisa M Shulman; W Wiener; D Bateman-Rodriguez; A Carrion; O Suchowersky; A L Lafontaine; C Pantella; E Siemers; J Belden; R Davies; M Lannon; D Grimes; P Gray; W Martin; L Kennedy; Charles H Adler; S Newman; John P Hammerstad; C Stone; Peter LeWitt; K Bardram; K Mistura; J Miyasaki; L Johnston; Jang-Ho Cha; M Tennis; M Panniset; J Hall; J Tetrud; J Friedlander; Robert A Hauser; L Gauger; R Rodnitzky; A Deleo; J Dobson; L Seeberger; C Dingmann; D Tarsy; P Ryan; L Elmer; D Ruzicka; M Stacy; M Brewer; B Locke; D Baker; C Casaceli; D Day; M Florack; K Hodgeman; N Laroia; R Nobel; C Orme; L Rexo; K Rothenburgh; K Sulimowicz; A Watts; E Wratni; Pierre N. Tariot; Christopher Cox; C Leventhal; V Alderfer; A M Craun; J Frey; L McCree; J McDermott; J Cooper; T Holdich; B Read
A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease.
Neurology 2001;56(4):455-62.
2000: Dominic Thyagarajan; Susan Bressman; C Bruno; Serge Przedborski; S Shanske; T Lynch; Stanley Fahn; S DiMauro
A novel mitochondrial 12SrRNA point mutation in parkinsonism, deafness, and neuropathy.
Annals of neurology 2000;48(5):730-6.
2000: Christine Klein; Karla Schilling; Rachel Saunders-Pullman; Jennifer Garrels; Xandra O Breakefield; Mitchell F Brin; D DeLeon; Dana Doheny; Stanley Fahn; J S Fink; Lars Forsgren; Jennifer Friedman; S Frucht; Juliette Harris; Gösta Holmgren; Bernhard Kis; Roger Kurlan; M Kyllerman; Anthony E Lang; Joanne Leung; Deborah Raymond; J D Robishaw; G Sanner; Eberhard Schwinger; Rowena Tabamo; Michele Tagliati
A major locus for myoclonus-dystonia maps to chromosome 7q in eight families.
American journal of human genetics 2000;67(5):1314-9.
2000: Steven Frucht; P E Greene; Stanley Fahn
Sleep episodes in Parkinson's disease: a wake-up call.
Movement disorders : official journal of the Movement Disorder Society 2000;15(4):601-3.
2000: Susan Bressman; C Sabatti; Deborah Raymond; Deborah de Leon; Christine Klein; Patricia L Kramer; Mitchell F Brin; Stanley Fahn; Xandra O Breakefield; Laurie J Ozelius; Neil J Risch
The DYT1 phenotype and guidelines for diagnostic testing.
Neurology 2000;54(9):1746-52.
2000: Stanley Fahn
The spectrum of levodopa-induced dyskinesias.
Annals of neurology 2000;47(4 Suppl 1):S2-9; discussion S9-11.
2000: Yoshiaki Furukawa; Oleh Hornykiewicz; Stanley Fahn; Stephen J Kish
Striatal dopamine in early-onset primary torsion dystonia with the DYT1 mutation.
Neurology 2000;54(5):1193-5.
2000: Steven Frucht; Stanley Fahn; B Ford
Focal task-specific dystonia induced by peripheral trauma.
Movement disorders : official journal of the Movement Disorder Society 2000;15(2):348-50.
2000: Steven Frucht; Stanley Fahn; S Chin; Vijay Dhawan; David Eidelberg
Levodopa-induced dyskinesias in autopsy-proven cortical-basal ganglionic degeneration.
Movement disorders : official journal of the Movement Disorder Society 2000;15(2):340-3.
2000: Curt R Freed; Robert E Breeze; Stanley Fahn
Placebo surgery in trials of therapy for Parkinson's disease.
The New England journal of medicine 2000;342(5):353-4; author reply 354-5.
2000: Steven Frucht; Stanley Fahn
The clinical spectrum of posthypoxic myoclonus.
Movement disorders : official journal of the Movement Disorder Society 2000;15 Suppl 1():2-7.
1999: Laurie J Ozelius; CE Page; Christine Klein; Jeffrey W Hewett; M Mineta; Joanne Leung; Christo Shalish; Susan Bressman; Deborah de Leon; Mitchell F Brin; Stanley Fahn; David P Corey; Xandra O Breakefield
The TOR1A (DYT1) gene family and its role in early onset torsion dystonia.
Genomics 1999;62(3):377-84.
1999: Yves Agid; E Ahlskog; A Albanese; Donald B Calne; Thomas N Chase; J De Yebenes; Stewart A Factor; Stanley Fahn; Oscar S Gershanik; Christopher G Goetz; William Koller; M Kurth; Anthony E Lang; Andrew J Lees; Peter LeWitt; D Marsden; Eldad Melamed; Patrick P Michel; Yoshikuni Mizuno; Jose A Obeso; Wolfgang H Oertel; W Olanow; Werner Poewe; Pierre Pollak; Eduardo Tolosa
Levodopa in the treatment of Parkinson's disease: a consensus meeting.
Movement disorders : official journal of the Movement Disorder Society 1999;14(6):911-3.
1999: Steven Frucht; Stanley Fahn; B Ford; M Gelb
A geste antagoniste device to treat jaw-closing dystonia.
Movement disorders : official journal of the Movement Disorder Society 1999;14(5):883-6.
1999: Steven Frucht; Stanley Fahn
Paroxysmal kinesigenic dyskinesia in infancy.
Movement disorders : official journal of the Movement Disorder Society 1999;14(4):694-5.
1999: Steven Frucht; John Rogers; P E Greene; Mark F Gordon; Stanley Fahn
Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole.
Neurology 1999;52(9):1908-10.
1999: Stanley Fahn
Parkinson disease, the effect of levodopa, and the ELLDOPA trial. Earlier vs Later L-DOPA.
Archives of neurology 1999;56(5):529-35.
1999: Christine Klein; Mitchell F Brin; Patricia L Kramer; Miguel Sena-Esteves; Deborah de Leon; Dana Doheny; Susan Bressman; Stanley Fahn; Xandra O Breakefield; Laurie J Ozelius
Association of a missense change in the D2 dopamine receptor with myoclonus dystonia.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(9):5173-6.
1999: Rachel Saunders-Pullman; J Gordon-Elliott; M Parides; Stanley Fahn; H R Saunders; Susan Bressman
The effect of estrogen replacement on early Parkinson's disease.
Neurology 1999;52(7):1417-21.
1999: Steven Frucht; Stanley Fahn; K M Shannon; C H Waters
A 32-year-old man with progressive spasticity and parkinsonism.
Movement disorders : official journal of the Movement Disorder Society 1999;14(2):350-7.
1999: Steven Frucht; Stanley Fahn; B Ford
French horn embouchure dystonia.
Movement disorders : official journal of the Movement Disorder Society 1999;14(1):171-3.
1998: Stanley Fahn
Medical treatment of Parkinson's disease.
Journal of neurology 1998;245(11 Suppl 3):P15-24.
1998: A Lieberman; C Warren Olanow; Kapil D Sethi; P Swanson; C H Waters; Stanley Fahn; Howard I Hurtig; M Yahr
A multicenter trial of ropinirole as adjunct treatment for Parkinson's disease. Ropinirole Study Group.
Neurology 1998;51(4):1057-62.
1998: Blair Ford; Elan D Louis; P Greene; Stanley Fahn
Outcome of selective ramisectomy for botulinum toxin resistant torticollis.
Journal of neurology, neurosurgery, and psychiatry 1998;65(4):472-8.
1998: Stanley Fahn; K E Clarence-Smith; Thomas N Chase
Parkinson's disease: neurodegenerative mechanisms and neuroprotective interventions--report of a workshop.
Movement disorders : official journal of the Movement Disorder Society 1998;13(5):759-67.
1998: David Eidelberg; James R Moeller; Angelo Antonini; K Kazumata; T Nakamura; Vijay Dhawan; Phoebe Spetsieris; D DeLeon; Susan Bressman; Stanley Fahn
Functional brain networks in DYT1 dystonia.
Annals of neurology 1998;44(3):303-12.
1998: SD Tabbal; Stanley Fahn; S Frucht
Fetal tissue transplantation [correction of transplanation] in Parkinson's disease.
Current opinion in neurology 1998;11(4):341-9.
1998: Stanley Fahn
Videotapes of motor complications of encephalitis lethargica.
Movement disorders : official journal of the Movement Disorder Society 1998;13(4):752-3.
1998: Michael Hutton; C L Lendon; P Rizzu; M Baker; S Froelich; H Houlden; S Pickering-Brown; S Chakraverty; A Isaacs; Andrew Grover; J Hackett; J Adamson; Sarah J Lincoln; dennis dickson; Peter Davies; Ronald C. Petersen; M Stevens; E de Graaff; E Wauters; J van Baren; M Hillebrand; M Joosse; J M Kwon; P Nowotny; L K Che; J Norton; John C Morris; L A Reed; John Q Trojanowski; Hans Basun; Lars Lannfelt; M Neystat; Stanley Fahn; F Dark; T Tannenberg; P R Dodd; N Hayward; J B Kwok; P R Schofield; A Andreadis; J Snowden; D Craufurd; David Neary; F Owen; B A Oostra; John Hardy; Alison Goate; J van Swieten; D M A Mann; T Lynch; Peter Heutink
Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17.
Nature 1998;393(6686):702-5.
1998: Govind T Vatassery; Stanley Fahn; M A Kuskowski
Alpha tocopherol in CSF of subjects taking high-dose vitamin E in the DATATOP study. Parkinson Study Group.
Neurology 1998;50(6):1900-2.
1998: Arif Dalvi; Stanley Fahn; B Ford
Intrathecal baclofen in the treatment of dystonic storm.
Movement disorders : official journal of the Movement Disorder Society 1998;13(3):611-2.
1998: Stanley Fahn
Tolcapone: COMT inhibition for the treatment of Parkinson's disease.
Neurology 1998;50(5 Suppl 5):S1-2.
1998: Stanley Fahn
Welcome news about levodopa, but uncertainty remains.
Annals of neurology 1998;43(5):551-4.
1998: William T Dauer; R E Burke; P Greene; Stanley Fahn
Current concepts on the clinical features, aetiology and management of idiopathic cervical dystonia.
Brain : a journal of neurology 1998;121 ( Pt 4)():547-60.
1998: CD Marsden; Stanley Fahn
Dystomia 3. Summary and conclusions.
Advances in neurology 1998;78():359-64.
1998: Kirk Wilhelmsen; C B Moskowitz; D E Weeks; M Neystat; TG Nygaard; L Clark; M Dancoup; E E Sobrevega; R Rosales; G L Gamez; O Pacioles; M Perez; Stanley Fahn
Molecular genetic analysis of Lubag.
Advances in neurology 1998;78():341-8.
1998: Blair Ford; Paul Greene; Elan D Louis; Susan Bressman; Robert R Goodman; Mitchell F Brin; S Sadiq; Stanley Fahn
Intrathecal baclofen in the treatment of dystonia.
Advances in neurology 1998;78():199-210.
1998: Susan Bressman; Deborah de Leon; Deborah Raymond; Paul Greene; Mitchell F Brin; Stanley Fahn; Laurie J Ozelius; Xandra O Breakefield; Patricia L Kramer; Neil J Risch
The role of the DYT1 gene in secondary dystonia.
Advances in neurology 1998;78():107-15.
1998: Laurie J Ozelius; Jeffrey W Hewett; CE Page; Susan Bressman; Patricia L Kramer; Christo Shalish; Deborah de Leon; Mitchell F Brin; Deborah Raymond; D Jacoby; John B Penney; Neil J Risch; Stanley Fahn; James Gusella; Xandra O Breakefield
The gene (DYT1) for early-onset torsion dystonia encodes a novel protein related to the Clp protease/heat shock family.
Advances in neurology 1998;78():93-105.
1998: Stanley Fahn; Susan Bressman; CD Marsden
Classification of dystonia.
Advances in neurology 1998;78():1-10.
1998: Stanley Fahn; R Elliott
Highlights of the Parkinson's Disease Foundation.
Movement disorders : official journal of the Movement Disorder Society 1998;13 Suppl 1():2-6.
1998: Stanley Fahn; S Chouinard
Experience with tranylcypromine in early Parkinson's disease.
Journal of neural transmission. Supplementum 1998;52():49-61.
1997: S Chouinard; Elan D Louis; Stanley Fahn
Agreement among movement disorder specialists on the clinical diagnosis of essential tremor.
Movement disorders : official journal of the Movement Disorder Society 1997;12(6):973-6.
1997: Laura A Almasy; Susan Bressman; Deborah Raymond; Patricia L Kramer; Paul Greene; Gary A Heiman; Blair Ford; J Yount; Deborah de Leon; S Chouinard; Rachel Saunders-Pullman; Mitchell F Brin; R P Kapoor; A C Jones; H Shen; Stanley Fahn; Neil J Risch; TG Nygaard
Idiopathic torsion dystonia linked to chromosome 8 in two Mennonite families.
Annals of neurology 1997;42(4):670-3.
1997: Laurie J Ozelius; Jeffrey W Hewett; CE Page; Susan Bressman; Patricia L Kramer; Christo Shalish; Deborah de Leon; Mitchell F Brin; Deborah Raymond; David P Corey; Stanley Fahn; Neil J Risch; AJ Buckler; James Gusella; Xandra O Breakefield
The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein.
Nature genetics 1997;17(1):40-8.
1997: T Lynch; Stanley Fahn; Elan D Louis; Jeffrey G Odel
Oculofacial-skeletal myorhythmia in Whipple's disease.
Movement disorders : official journal of the Movement Disorder Society 1997;12(4):625-6.
1997: T Lynch; Jeffrey G Odel; D N Fredericks; Elan D Louis; S Forman; Heidrun Rotterdam; Stanley Fahn; D A Relman
Polymerase chain reaction-based detection of Tropheryma whippelii in central nervous system Whipple's disease.
Annals of neurology 1997;42(1):120-4.
1997: Susan Bressman; Deborah de Leon; Deborah Raymond; Paul Greene; Mitchell F Brin; Stanley Fahn; Laurie J Ozelius; Xandra O Breakefield; Patricia L Kramer; Neil J Risch
Secondary dystonia and the DYTI gene.
Neurology 1997;48(6):1571-7.
1997: Nir Giladi; R Kao; Stanley Fahn
Freezing phenomenon in patients with parkinsonian syndromes.
Movement disorders : official journal of the Movement Disorder Society 1997;12(3):302-5.
1997: Laurie J Ozelius; Jeffrey W Hewett; Patricia L Kramer; Susan Bressman; Christo Shalish; Deborah de Leon; M Rutter; Neil Risch; Mitchell F Brin; Elena D Markova; Svetlana A Limborska; Irina A Ivanova-Smolenskaya; M K McCormick; Stanley Fahn; AJ Buckler; James Gusella; Xandra O Breakefield
Fine localization of the torsion dystonia gene (DYT1) on human chromosome 9q34: YAC map and linkage disequilibrium.
Genome research 1997;7(5):483-94.
1997: Stanley Fahn
An overview of novel therapies for Parkinson's disease.
Experimental neurology 1997;144(1):21-3.
1997: Roger Kurlan; M F Brin; Stanley Fahn
Movement disorder in reflex sympathetic dystrophy: a case proven to be psychogenic by surveillance video monitoring.
Movement disorders : official journal of the Movement Disorder Society 1997;12(2):243-5.
1997: Elan D Louis; L A Klatka; Y Liu; Stanley Fahn
Comparison of extrapyramidal features in 31 pathologically confirmed cases of diffuse Lewy body disease and 34 pathologically confirmed cases of Parkinson's disease.
Neurology 1997;48(2):376-80.
1997: Elan D Louis; Ruth Ottman; Blair Ford; Seth L Pullman; M Martinez; Stanley Fahn; W Allen Hauser
The Washington Heights-Inwood Genetic Study of Essential Tremor: methodologic issues in essential-tremor research.
Neuroepidemiology 1997;16(3):124-33.
1997: A Tan; M Salgado; Stanley Fahn
The characterization and outcome of stereotypical movements in nonautistic children.
Movement disorders : official journal of the Movement Disorder Society 1997;12(1):47-52.
1996: C Warren Olanow; Stanley Fahn; J William Langston; J Godbold
Selegiline and mortality in Parkinson's disease.
Annals of neurology 1996;40(6):841-5.
1996: Blair Ford; P Greene; Elan D Louis; G Petzinger; Susan Bressman; R Goodman; Mitchell F Brin; S Sadiq; Stanley Fahn
Use of intrathecal baclofen in the treatment of patients with dystonia.
Archives of neurology 1996;53(12):1241-6.
1996: Stanley Fahn
Is levodopa toxic?
Neurology 1996;47(6 Suppl 3):S184-95.
1996: Susan Bressman; T T Warner; Laura A Almasy; Ryan Uitti; Paul Greene; Gary A Heiman; Deborah Raymond; Blair Ford; Deborah de Leon; Stanley Fahn; Patricia L Kramer; N J Risch; Demetrius M Maraganore; TG Nygaard; A E Harding
Exclusion of the DYT1 locus in familial torticollis.
Annals of neurology 1996;40(4):681-4.
1996: Elan D Louis; T Lynch; P Kaufmann; Stanley Fahn; Jeffrey G Odel
Diagnostic guidelines in central nervous system Whipple's disease.
Annals of neurology 1996;40(4):561-8.
1996: Seth L Pullman; P Greene; Stanley Fahn; S F Pedersen
Approach to the treatment of limb disorders with botulinum toxin A. Experience with 187 patients.
Archives of neurology 1996;53(7):617-24.
1996: G Erenberg; Stanley Fahn
Tourette syndrome.
Archives of neurology 1996;53(7):588.
1996: Blair Ford; Elan D Louis; P Greene; Stanley Fahn
Oral and genital pain syndromes in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1996;11(4):421-6.
1996: Stanley Fahn; Mitchell F Brin; A J Dwork; William J Weiner; Christopher G Goetz; Ali H Rajput
Case 1, 1996: rapidly progressive parkinsonism, incontinence, impotency, and levodopa-induced moaning in a patient with multiple myeloma.
Movement disorders : official journal of the Movement Disorder Society 1996;11(3):298-310.
1996: Elan D Louis; T Lynch; Blair Ford; P Greene; Susan Bressman; Stanley Fahn
Delayed-onset cerebellar syndrome.
Archives of neurology 1996;53(5):450-4.
1996: A Tan; M Salgado; Stanley Fahn
Rapid eye movement sleep behavior disorder preceding Parkinson's disease with therapeutic response to levodopa.
Movement disorders : official journal of the Movement Disorder Society 1996;11(2):214-6.
1996: Elan D Louis; T Lynch; Karen Marder; Stanley Fahn
Reliability of patient completion of the historical section of the Unified Parkinson's Disease Rating Scale.
Movement disorders : official journal of the Movement Disorder Society 1996;11(2):185-92.
1996: P E Greene; Stanley Fahn
Response to botulinum toxin F in seronegative botulinum toxin A--resistant patients.
Movement disorders : official journal of the Movement Disorder Society 1996;11(2):181-4.
1996: Seth L Pullman; Blair Ford; B Elibol; Antonino Uncini; P C Su; Stanley Fahn
Cutaneous electromyographic silent period findings in brachial dystonia.
Neurology 1996;46(2):503-8.
1996: Stanley Fahn
Controversies in the therapy of Parkinson's disease.
Advances in neurology 1996;69():477-86.
1996: Elan D Louis; Stanley Fahn
Pathologically diagnosed diffuse Lewy body disease and Parkinson's disease. Do the parkinsonian features differ?
Advances in neurology 1996;69():311-4.
1995: David Eidelberg; James R Moeller; T Ishikawa; Vijay Dhawan; Phoebe Spetsieris; Serge Przedborski; Stanley Fahn
The metabolic topography of idiopathic torsion dystonia.
Brain : a journal of neurology 1995;118 ( Pt 6)():1473-84.
1995: Elan D Louis; T Lynch; A L Cargan; Stanley Fahn
Generalized chorea in an infant with semilobar holoprosencephaly.
Pediatric neurology 1995;13(4):355-7.
1995: David Eidelberg; James R Moeller; T Ishikawa; Vijay Dhawan; Phoebe Spetsieris; Thomas Chaly; A Belakhlef; F Mandel; Serge Przedborski; Stanley Fahn
Early differential diagnosis of Parkinson's disease with 18F-fluorodeoxyglucose and positron emission tomography.
Neurology 1995;45(11):1995-2004.
1995: C Stewart; L Winfield; A Hunt; Susan Bressman; Stanley Fahn; A Blitzer; M F Brin
Speech dysfunction in early Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1995;10(5):562-5.
1995: Anthony E Lang; William Koller; Stanley Fahn
Psychogenic parkinsonism.
Archives of neurology 1995;52(8):802-10.
1995: Gösta Holmgren; L Ozelius; L Forsgren; B G Almay; M Holmberg; Patricia L Kramer; Stanley Fahn; X O Breakefield
Adult onset idiopathic torsion dystonia is excluded from the DYT 1 region (9q34) in a Swedish family.
Journal of neurology, neurosurgery, and psychiatry 1995;59(2):178-81.
1995: M F Gordon; Susan Bressman; Mitchell F Brin; Deborah de Leon; D Warburton; K Yeboa; Stanley Fahn
Dystonia in a patient with deletion of 18q.
Movement disorders : official journal of the Movement Disorder Society 1995;10(4):496-9.
1995: Michael P McDermott; Joseph Jankovic; Julie H Carter; Stanley Fahn; S Gauthier; Christopher G Goetz; Lawrence I Golbe; William Koller; Anthony E Lang; C Warren Olanow
Factors predictive of the need for levodopa therapy in early, untreated Parkinson's disease. The Parkinson Study Group.
Archives of neurology 1995;52(6):565-70.
1995: Serge Przedborski; Vernice Jackson-Lewis; Stanley Fahn
Antiparkinsonian therapies and brain mitochondrial complex I activity.
Movement disorders : official journal of the Movement Disorder Society 1995;10(3):312-7.
1995: Christopher G Goetz; Glenn T Stebbins; T A Chmura; Stanley Fahn; H L Klawans; CD Marsden
Teaching tape for the motor section of the unified Parkinson's disease rating scale.
Movement disorders : official journal of the Movement Disorder Society 1995;10(3):263-6.
1995: Elan D Louis; J E Goldman; J M Powers; Stanley Fahn
Parkinsonian features of eight pathologically diagnosed cases of diffuse Lewy body disease.
Movement disorders : official journal of the Movement Disorder Society 1995;10(2):188-94.
1995: P Greene; U J Kang; Stanley Fahn
Spread of symptoms in idiopathic torsion dystonia.
Movement disorders : official journal of the Movement Disorder Society 1995;10(2):143-52.
1995: N Risch; Deborah de Leon; Laurie J Ozelius; Patricia L Kramer; Laura A Almasy; B Singer; Stanley Fahn; X Breakefield; Susan Bressman
Genetic analysis of idiopathic torsion dystonia in Ashkenazi Jews and their recent descent from a small founder population.
Nature genetics 1995;9(2):152-9.
1995: Stanley Fahn
The freezing phenomenon in parkinsonism.
Advances in neurology 1995;67():53-63.
1995: Blair Ford; Stanley Fahn; Seth L Pullman
Peripherally induced EMG silent periods. Normal physiology and disorders of motor control.
Advances in neurology 1995;67():321-8.
1995: D T Williams; B Ford; Stanley Fahn
Phenomenology and psychopathology related to psychogenic movement disorders.
Advances in neurology 1995;65():231-57.
1994: Susan Bressman; Deborah de Leon; Patricia L Kramer; Laurie J Ozelius; Mitchell F Brin; Paul Greene; Stanley Fahn; Xandra O Breakefield; N J Risch
Dystonia in Ashkenazi Jews: clinical characterization of a founder mutation.
Annals of neurology 1994;36(5):771-7.
1994: Blair Ford; P Greene; Stanley Fahn
Oral and genital tardive pain syndromes.
Neurology 1994;44(11):2115-9.
1994: Susan Bressman; A L Hunt; Gary A Heiman; Mitchell F Brin; Robert E Burke; Stanley Fahn; JM Trugman; Deborah de Leon; Patricia L Kramer; Kirk Wilhelmsen
Exclusion of the DYT1 locus in a non-Jewish family with early-onset dystonia.
Movement disorders : official journal of the Movement Disorder Society 1994;9(6):626-32.
1994: Stanley Fahn; Richard Mayeux; L P Rowland
A new eponym: Wilhelmsen-Lynch disease.
Neurology 1994;44(10):1980.
1994: T Lynch; Mary Sano; Karen Marder; K L Bell; Norman L Foster; R F Defendini; Anders A F Sima; C Keohane; TG Nygaard; Stanley Fahn
Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy complex.
Neurology 1994;44(10):1878-84.
1994: Seth L Pullman; B Elibol; Stanley Fahn
Modulation of parkinsonian tremor by radial nerve palsy.
Neurology 1994;44(10):1861-4.
1994: Serge Przedborski; Nir Giladi; S Takikawa; T Ishikawa; Vijay Dhawan; Phoebe Spetsieris; Thomas Chaly; Stanley Fahn; David Eidelberg
Metabolic topography of the hemiparkinsonism-hemiatrophy syndrome.
Neurology 1994;44(9):1622-8.
1994: B Ford; Stanley Fahn
Intrathecal baclofen.
Neurology 1994;44(7):1367-8.
1994: Mark F Lew; M Shindo; C B Moskowitz; Kirk Wilhelmsen; Stanley Fahn; CH Waters
Adductor laryngeal breathing dystonia in a patient with lubag (X-linked dystonia-Parkinsonism syndrome).
Movement disorders : official journal of the Movement Disorder Society 1994;9(3):318-20.
1994: P Greene; Stanley Fahn; B Diamond
Development of resistance to botulinum toxin type A in patients with torticollis.
Movement disorders : official journal of the Movement Disorder Society 1994;9(2):213-7.
1994: Jan Wahlström; Laurie J Ozelius; Patricia L Kramer; Mårten Kyllerman; D Schuback; L Forsgren; Gösta Holmgren; U Drugge; G Sanner; Stanley Fahn
The gene for familial dystonia with myoclonic jerks responsive to alcohol is not located on the distal end of 9q.
Clinical genetics 1994;45(2):88-92.
1994: T Lynch; R E Burke; Stanley Fahn
Progress in psychiatry.
The New England journal of medicine 1994;330(4):285-6.
1994: John Rogers; Stanley Fahn
Movement disorders and pregnancy.
Advances in neurology 1994;64():163-78.
1994: C Warren Olanow; Stanley Fahn; M Muenter; H Klawans; Howard I Hurtig; Matthew B Stern; Ira Shoulson; Roger Kurlan; J D Grimes; Joseph Jankovic
A multicenter double-blind placebo-controlled trial of pergolide as an adjunct to Sinemet in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1994;9(1):40-7.
1993: TG Nygaard; Kirk Wilhelmsen; N J Risch; D L Brown; JM Trugman; T Conrad Gilliam; Stanley Fahn; Daniel E Weeks
Linkage mapping of dopa-responsive dystonia (DRD) to chromosome 14q.
Nature genetics 1993;5(4):386-91.
1993: Serge Przedborski; Vernice Jackson-Lewis; U Muthane; H Jiang; M Ferreira; Ali Naini; Stanley Fahn
Chronic levodopa administration alters cerebral mitochondrial respiratory chain activity.
Annals of neurology 1993;34(5):715-23.
1993: M F Gordon; R Diaz-Olivo; A L Hunt; Stanley Fahn
Therapeutic trial of milacemide in patients with myoclonus and other intractable movement disorders.
Movement disorders : official journal of the Movement Disorder Society 1993;8(4):484-8.
1993: P E Greene; Stanley Fahn
Use of botulinum toxin type F injections to treat torticollis in patients with immunity to botulinum toxin type A.
Movement disorders : official journal of the Movement Disorder Society 1993;8(4):479-83.
1993: Nir Giladi; M Sutton; B Lo; Serge Przedborski; Stanley Fahn; J L Cadet
Toxicity of the specific antimuscarinic agent methoctramine and other non-specific anticholinergic drugs in human neuroblastoma cell lines in vitro.
Toxicology in vitro : an international journal published in association with BIBRA 1993;7(5):595-603.
1993: David Eidelberg; S Takikawa; Vijay Dhawan; Thomas Chaly; W Robeson; R Dahl; D Margouleff; James R Moeller; C S Patlak; Stanley Fahn
Striatal 18F-dopa uptake: absence of an aging effect.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 1993;13(5):881-8.
1993: CH Waters; H Takahashi; Kirk Wilhelmsen; R Shubin; BJ Snow; TG Nygaard; C B Moskowitz; Stanley Fahn; Donald B Calne
Phenotypic expression of X-linked dystonia-parkinsonism (lubag) in two women.
Neurology 1993;43(8):1555-8.
1993: CH Waters; P L Faust; J Powers; H Vinters; C Moskowitz; TG Nygaard; A L Hunt; Stanley Fahn
Neuropathology of lubag (x-linked dystonia parkinsonism).
Movement disorders : official journal of the Movement Disorder Society 1993;8(3):387-90.
1993: B Pardo; Maria Angeles Mena; Stanley Fahn; Justo García De Yébenes
Ascorbic acid protects against levodopa-induced neurotoxicity on a catecholamine-rich human neuroblastoma cell line.
Movement disorders : official journal of the Movement Disorder Society 1993;8(3):278-84.
1993: andrew dwork; C Balmaceda; E A Fazzini; M MacCollin; Lucien J Cote; Stanley Fahn
Dominantly inherited, early-onset parkinsonism: neuropathology of a new form.
Neurology 1993;43(1):69-74.
1993: P Greene; Lucien J Cote; Stanley Fahn
Treatment of drug-induced psychosis in Parkinson's disease with clozapine.
Advances in neurology 1993;60():703-6.
1993: Stanley Fahn
Future strategies for the treatment of Parkinson's disease.
Advances in neurology 1993;60():636-40.
1993: Serge Przedborski; S Goldman; Nir Giladi; Vijay Dhawan; S Takikawa; J Hildebrand; Stanley Fahn; David Eidelberg
Positron emission tomography in hemiparkinsonism-hemiatrophy syndrome.
Advances in neurology 1993;60():501-5.
1992: Stanley Fahn; G Cohen
The oxidant stress hypothesis in Parkinson's disease: evidence supporting it.
Annals of neurology 1992;32(6):804-12.
1992: Stanley Fahn
Fetal-tissue transplants in Parkinson's disease.
The New England journal of medicine 1992;327(22):1589-90.
1992: TG Nygaard; H Takahashi; Gary A Heiman; BJ Snow; Stanley Fahn; Donald B Calne
Long-term treatment response and fluorodopa positron emission tomographic scanning of parkinsonism in a family with dopa-responsive dystonia.
Annals of neurology 1992;32(5):603-8.
1992: Nir Giladi; Stanley Fahn
Hemiparkinsonism-hemiatrophy syndrome may mimic early-stage cortical-basal ganglionic degeneration.
Movement disorders : official journal of the Movement Disorder Society 1992;7(4):384-5.
1992: Thomas Gasser; Stanley Fahn; Xandra O Breakefield
The autosomal dominant dystonias.
Brain pathology (Zurich, Switzerland) 1992;2(4):297-308.
1992: Barry S Russman; Anthony E Lang; Stanley Fahn; P Greene; Margaret L Grunnet
What is it? Case 1, 1992: progressive gait deterioration, peripheral neuropathy, optic atrophy, bradykinesia, and dystonia in a young girl.
Movement disorders : official journal of the Movement Disorder Society 1992;7(4):373-9.
1992: Anthony E Lang; Niall Quinn; CD Marsden; L Findley; William Koller; M Brin; Stanley Fahn
Essential tremor.
Neurology 1992;42(7):1432-4.
1992: SM Zhu; K Kujirai; A Dollison; J Angulo; Stanley Fahn; J L Cadet
Implantation of genetically modified mesencephalic fetal cells into the rat striatum.
Brain research bulletin 1992;29(1):81-93.
1992: Serge Przedborski; V Kostic; Vernice Jackson-Lewis; Ali Naini; S Simonetti; Stanley Fahn; E Carlson; C J Epstein; J L Cadet
Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1992;12(5):1658-67.
1992: Andrew Blitzer; Mitchell F Brin; C Stewart; Jonathan E Aviv; Stanley Fahn
Abductor laryngeal dystonia: a series treated with botulinum toxin.
The Laryngoscope 1992;102(2):163-7.
1992: Nir Giladi; Don McMahon; Serge Przedborski; E Flaster; S Guillory; V Kostic; Stanley Fahn
Motor blocks in Parkinson's disease.
Neurology 1992;42(2):333-9.
1992: Paul Greene; Stanley Fahn
Baclofen in the treatment of idiopathic dystonia in children.
Movement disorders : official journal of the Movement Disorder Society 1992;7(1):48-52.
1992: Maria Angeles Mena; B Pardo; Maria José Casarejos; Stanley Fahn; Justo García De Yébenes
Neurotoxicity of levodopa on catecholamine-rich neurons.
Movement disorders : official journal of the Movement Disorder Society 1992;7(1):23-31.
1992: J William Langston; Håkan Widner; Christopher G Goetz; D Brooks; Stanley Fahn; T Freeman; Ray L Watts
Core assessment program for intracerebral transplantations (CAPIT).
Movement disorders : official journal of the Movement Disorder Society 1992;7(1):2-13.
1992: Stanley Fahn
A pilot trial of high-dose alpha-tocopherol and ascorbate in early Parkinson's disease.
Annals of neurology 1992;32 Suppl():S128-32.
1992: E Fazzini; J Fleming; Stanley Fahn
Cerebrospinal fluid antibodies to coronavirus in patients with Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1992;7(2):153-8.
1991: Nir Giladi; P Greene; Stanley Fahn
[Botulinum toxin as a powerful new tool in the treatment of focal dystonia].
Harefuah 1991;121(11):475-8.
1991: David Eidelberg; Vijay Dhawan; J R Moeller; John J Sidtis; J Z Ginos; Stephen C Strother; J Cederbaum; P Greene; Stanley Fahn; J M Powers
The metabolic landscape of cortico-basal ganglionic degeneration: regional asymmetries studied with positron emission tomography.
Journal of neurology, neurosurgery, and psychiatry 1991;54(10):856-62.
1991: David J Kwiatkowski; Laurie J Ozelius; Patricia L Kramer; S Perman; D E Schuback; James Gusella; Stanley Fahn; Xandra O Breakefield
Torsion dystonia genes in two populations confined to a small region on chromosome 9q32-34.
American journal of human genetics 1991;49(2):366-71.
1991: A Blitzer; M F Brin; Stanley Fahn
Botulinum toxin injections for lingual dystonia.
The Laryngoscope 1991;101(7 Pt 1):799.
1991: Dale J Lange; M Rubin; Paul Greene; U J Kang; C B Moskowitz; Mitchell F Brin; R E Lovelace; Stanley Fahn
Distant effects of locally injected botulinum toxin: a double-blind study of single fiber EMG changes.
Muscle & nerve 1991;14(7):672-5.
1991: K Kujirai; Stanley Fahn; J L Cadet
Receptor autoradiography of mu and delta opioid peptide receptors in spontaneously hypertensive rats.
Peptides 1991;12(4):779-85.
1991: Serge Przedborski; Marc Levivier; V Kostic; Vernice Jackson-Lewis; A Dollison; D M Gash; Stanley Fahn; J L Cadet
Sham transplantation protects against 6-hydroxydopamine-induced dopaminergic toxicity in rats: behavioral and morphological evidence.
Brain research 1991;550(2):231-8.
1991: Marie H Saint-Hilaire; R E Burke; Susan Bressman; M F Brin; Stanley Fahn
Delayed-onset dystonia due to perinatal or early childhood asphyxia.
Neurology 1991;41(2 ( Pt 1)):216-22.
1991: TG Nygaard; CD Marsden; Stanley Fahn
Dopa-responsive dystonia: long-term treatment response and prognosis.
Neurology 1991;41(2 ( Pt 1)):174-81.
1991: Vernice Jackson-Lewis; Serge Przedborski; V Kostic; F Suber; Stanley Fahn; J L Cadet
Partial attenuation of chronic fluphenazine-induced changes in regional monoamine metabolism by D-alpha-tocopherol in rat brain.
Brain research bulletin 1991;26(2):251-8.
1991: Kirk Wilhelmsen; Daniel E Weeks; TG Nygaard; C B Moskowitz; R L Rosales; D C dela Paz; E E Sobrevega; Stanley Fahn; T Conrad Gilliam
Genetic mapping of "Lubag" (X-linked dystonia-parkinsonism) in a Filipino kindred to the pericentromeric region of the X chromosome.
Annals of neurology 1991;29(2):124-31.
1991: Stanley Fahn
The genetics of idiopathic torsion dystonia.
International journal of neurology 1991;25-26():70-80.
1991: J Chan; M F Brin; Stanley Fahn
Idiopathic cervical dystonia: clinical characteristics.
Movement disorders : official journal of the Movement Disorder Society 1991;6(2):119-26.
1991: Stanley Fahn
An open trial of high-dosage antioxidants in early Parkinson's disease.
The American journal of clinical nutrition 1991;53(1 Suppl):380S-382S.
1991: Stanley Fahn; O Sjaastad
Hereditary essential myoclonus in a large Norwegian family.
Movement disorders : official journal of the Movement Disorder Society 1991;6(3):237-47.
1991: Serge Przedborski; Vernice Jackson-Lewis; Sulli Popilskis; V Kostic; Marc Levivier; Stanley Fahn; J L Cadet
Unilateral MPTP-induced parkinsonism in monkeys. A quantitative autoradiographic study of dopamine D1 and D2 receptors and re-uptake sites.
Neuro-Chirurgie 1991;37(6):377-82.
1991: Federico Micheli; M Fernandez Pardal; R Giannaula; Stanley Fahn
What is it? Case 3, 1991: moaning in a man with parkinsonian signs.
Movement disorders : official journal of the Movement Disorder Society 1991;6(4):376-8.
1991: C J Vecht; J D Meerwaldt; A J Lees; CD Marsden; Stanley Fahn
What is it? Case 2, 1991: unusual tremor, myoclonus, and a limping gait.
Movement disorders : official journal of the Movement Disorder Society 1991;6(4):371-5.
1991: Gianni Pezzoli; A Zecchinelli; S Ricciardi; R E Burke; Stanley Fahn; Guglielmo Scarlato; A Carenzi
Intraventricular infusion of epidermal growth factor restores dopaminergic pathway in hemiparkinsonian rats.
Movement disorders : official journal of the Movement Disorder Society 1991;6(4):281-7.
1990: Nir Giladi; Robert E Burke; V Kostic; Serge Przedborski; M Gordon; A Hunt; Stanley Fahn
Hemiparkinsonism-hemiatrophy syndrome: clinical and neuroradiologic features.
Neurology 1990;40(11):1731-4.
1990: K Kujirai; Serge Przedborski; V Kostic; Vernice Jackson-Lewis; Stanley Fahn; J L Cadet
Autoradiography of dopamine receptors and dopamine uptake sites in the spontaneously hypertensive rat.
Brain research bulletin 1990;25(5):703-9.
1990: D H Park; U J Kang; C B Moskowitz; Robert E Burke; T H Joh; Stanley Fahn
Dopamine beta-hydroxylase activity in cerebrospinal fluid of idiopathic torsion dystonia.
Neurology 1990;40(10):1626-8.
1990: Serge Przedborski; M Wright; Stanley Fahn; J L Cadet
Quantitative autoradiographic changes in 5-[3H]HT-labeled 5-HT1 serotonin receptors in discrete regions of brain in the rat model of persistent dyskinesias induced by iminodipropionitrile (IDPN).
Neuroscience letters 1990;116(1-2):51-7.
1990: P Greene; U Kang; Stanley Fahn; M Brin; C Moskowitz; E Flaster
Double-blind, placebo-controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis.
Neurology 1990;40(8):1213-8.
1990: N J Risch; Susan Bressman; D DeLeon; Mitchell F Brin; Robert E Burke; Paul Greene; H Shale; Elizabeth B Claus; L A Cupples; Stanley Fahn
Segregation analysis of idiopathic torsion dystonia in Ashkenazi Jews suggests autosomal dominant inheritance.
American journal of human genetics 1990;46(3):533-8.
1990: TG Nygaard; JM Trugman; J G de Yebenes; Stanley Fahn
Dopa-responsive dystonia: the spectrum of clinical manifestations in a large North American family.
Neurology 1990;40(1):66-9.
1990: Stanley Fahn; R Burke; Yaakov Stern
Antimuscarinic drugs in the treatment of movement disorders.
Progress in brain research 1990;84():389-97.
1990: Paul Greene; Stanley Fahn; Anthony E Lang; Ray L Watts; David Eidelberg; J M Powers
What is it? Case 1, 1990: progressive unilateral rigidity, bradykinesia, tremulousness, and apraxia, leading to fixed postural deformity of the involved limb.
Movement disorders : official journal of the Movement Disorder Society 1990;5(4):341-51.
1990: David Eidelberg; J R Moeller; Vijay Dhawan; John J Sidtis; J Z Ginos; Stephen C Strother; Jesse Cedarbaum; P Greene; Stanley Fahn; David A Rottenberg
The metabolic anatomy of Parkinson's disease: complementary [18F]fluorodeoxyglucose and [18F]fluorodopa positron emission tomographic studies.
Movement disorders : official journal of the Movement Disorder Society 1990;5(3):203-13.
1990: J G de Yébenes; Stanley Fahn; R Goodman; Z Jamrosik; G Pezzoli; S Popalski
Intracerebroventricular infusion of (+)-4-propyl-9-hydroxy-naphthoxacine in monkeys with MPTP-induced akinesia.
Advances in neurology 1990;53():231-8.
1989: Serge Przedborski; M Wright; Stanley Fahn; J L Cadet
Regional changes in brain 5-HT1A serotonin receptors in the rat model of persistent spasmodic dyskinesias induced by iminodipropionitrile.
Brain research 1989;504(2):311-4.
1989: Serge Przedborski; M Wright; Stanley Fahn; J L Cadet
Autoradiographic evidence of [3H]neurotensin binding changes in discrete regions of brain in the rat model of persistent spasmodic dyskinesia induced by iminodipropionitrile.
Neuroscience letters 1989;107(1-3):335-40.
1989: A S Perumal; W K Tordzro; Mindy Katz; Vernice Jackson-Lewis; Thomas B Cooper; Stanley Fahn; J L Cadet
Regional effects of 6-hydroxydopamine (6-OHDA) on free radical scavengers in rat brain.
Brain research 1989;504(1):139-41.
1989: Susan Bressman; Deborah de Leon; Mitchell F Brin; N Risch; Robert E Burke; Paul Greene; H Shale; Stanley Fahn
Idiopathic dystonia among Ashkenazi Jews: evidence for autosomal dominant inheritance.
Annals of neurology 1989;26(5):612-20.
1989: Stanley Fahn
Clinical variants of idiopathic torsion dystonia.
Journal of neurology, neurosurgery, and psychiatry 1989;Suppl():96-100.
1989: Maria Angeles Mena; J Garcia de Yebenes; A Dwork; Stanley Fahn; N Latov; J Herbert; E Flaster; D Slonim
Biochemical properties of monoamine-rich human neuroblastoma cells.
Brain research 1989;486(2):286-96.
1989: D D Truong; matthew galloway; G Pezzoli; Z Jamrozik; Stanley Fahn
Milacemide increases 5-hydroxytryptamine and dopamine levels in rat brain--possible mechanisms of milacemide antimyoclonic property in the p,p'-DDT-induced myoclonus.
Pharmacology, biochemistry, and behavior 1989;32(4):993-1001.
1989: R Stennett; Mindy Katz; Vernice Jackson-Lewis; Stanley Fahn; J L Cadet
The protein synthesis inhibitor, anisomycin, causes exacerbation of the iminodipropionitrile-induced spasmodic dyskinetic syndrome in rats.
Pharmacology, biochemistry, and behavior 1989;32(4):1003-8.
1989: Andrew Blitzer; Mitchell F Brin; Paul Greene; Stanley Fahn
Botulinum toxin injection for the treatment of oromandibular dystonia.
The Annals of otology, rhinology, and laryngology 1989;98(2):93-7.
1989: J L Cadet; Mindy Katz; Vernice Jackson-Lewis; Stanley Fahn
Vitamin E attenuates the toxic effects of intrastriatal injection of 6-hydroxydopamine (6-OHDA) in rats: behavioral and biochemical evidence.
Brain research 1989;476(1):10-5.
1989: Mitchell F Brin; Andrew Blitzer; Stanley Fahn; W Gould; R E Lovelace
Adductor laryngeal dystonia (spastic dysphonia): treatment with local injections of botulinum toxin (Botox).
Movement disorders : official journal of the Movement Disorder Society 1989;4(4):287-96.
1989: D D Truong; B Diamond; G Pezzoli; Maria Angeles Mena; Stanley Fahn
Monoamine oxidase inhibitory properties of milacemide in rats.
Life sciences 1989;44(15):1059-66.
1989: Stanley Fahn
The endogenous toxin hypothesis of the etiology of Parkinson's disease and a pilot trial of high-dosage antioxidants in an attempt to slow the progression of the illness.
Annals of the New York Academy of Sciences 1989;570():186-96.
1989: Stanley Fahn
The history of parkinsonism.
Movement disorders : official journal of the Movement Disorder Society 1989;4 Suppl 1():S2-10.
1989: Robert E Burke; Un Jung Kang; Joseph Jankovic; L G Miller; Stanley Fahn
Tardive akathisia: an analysis of clinical features and response to open therapeutic trials.
Movement disorders : official journal of the Movement Disorder Society 1989;4(2):157-75.
1989: U J Kang; Stanley Fahn; H Schwarz; Ira Shoulson; H Vallejos; J Goldman
Case 1, 1989: juvenile-onset parkinsonism, dystonia, and pyramidal tract signs.
Movement disorders : official journal of the Movement Disorder Society 1989;4(4):363-70.
1989: J Thomas; Vernice Jackson-Lewis; Stanley Fahn; J L Cadet
Methylprednisolone treatments alter apomorphine-induced circling in the rat model of 6-hydroxydopamine-induced striatal denervation.
The International journal of neuroscience 1989;44(1-2):149-54.
1988: J Garcia de Yebenes; Stanley Fahn; Maria Angeles Mena; B Pardo; Maria José Casarejos
Intracerebroventricular infusion of dopamine and its agonists in rodents and primates. An experimental approach to the treatment of Parkinson's disease.
ASAIO transactions / American Society for Artificial Internal Organs 1988;34(4):951-7.
1988: G Pezzoli; Stanley Fahn; andrew dwork; D D Truong; J G de Yebenes; Vernice Jackson-Lewis; J Herbert; J L Cadet
Non-chromaffin tissue plus nerve growth factor reduces experimental parkinsonism in aged rats.
Brain research 1988;459(2):398-403.
1988: D D Troung; Susan Bressman; H Shale; Stanley Fahn
Clonazepam, haloperidol, and clonidine in tic disorders.
Southern medical journal 1988;81(9):1103-5.
1988: G T Vatassery; M F Brin; Stanley Fahn; H J Kayden; M G Traber
Effect of high doses of dietary vitamin E on the concentrations of vitamin E in several brain regions, plasma, liver, and adipose tissue of rats.
Journal of neurochemistry 1988;51(2):621-3.
1988: U J Kang; Stanley Fahn
Management of tardive dyskinesia.
Rational drug therapy 1988;22(8):1-7.
1988: J L Cadet; Vernice Jackson-Lewis; Stanley Fahn
The iminodipropionitrile (IDPN) model of persistent spasmodic dyskinesias: regional serotonin metabolism in rat brain.
Brain research 1988;456(2):371-4.
1988: A Blitzer; M F Brin; Stanley Fahn; R E Lovelace
Clinical and laboratory characteristics of focal laryngeal dystonia: study of 110 cases.
The Laryngoscope 1988;98(6 Pt 1):636-40.
1988: Richard Mayeux; Yaakov Stern; R Rosenstein; Karen Marder; A Hauser; Lucien J Cote; Stanley Fahn
An estimate of the prevalence of dementia in idiopathic Parkinson's disease.
Archives of neurology 1988;45(3):260-2.
1988: Stanley Fahn
Is the thought disorder with oculogyric crisis a feature of tardive akathisia or tardive dysphrenia?
Annals of neurology 1988;23(3):313-4.
1988: Andrew Blitzer; Mitchell F Brin; Stanley Fahn; R E Lovelace
Localized injections of botulinum toxin for the treatment of focal laryngeal dystonia (spastic dysphonia).
The Laryngoscope 1988;98(2):193-7.
1988: D D Truong; B Sczesni; Stanley Fahn; J Gross; K Donovan; A van Bakel; M K Wiley
[Neuroleptic malignant syndrome (dopamine-dependent malignant hyperthermia). 4 different cases].
Der Nervenarzt 1988;59(2):103-9.
1988: Catherine T Falk; Susan Bressman; F H Allen; C Moskowitz; Stanley Fahn; M Brin
Linkage studies in families with dystonia: linkage analysis as a tool to locate and characterize the gene(s) for dystonia.
Advances in neurology 1988;50():67-72.
1988: Mitchell F Brin; Stanley Fahn; C Moskowitz; A Friedman; H M Shale; Paul Greene; Andrew Blitzer; T List; D Lange; R E Lovelace
Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm.
Advances in neurology 1988;50():599-608.
1988: P Greene; H Shale; Stanley Fahn
Experience with high dosages of anticholinergic and other drugs in the treatment of torsion dystonia.
Advances in neurology 1988;50():547-56.
1988: Susan Bressman; Deborah de Leon; Mitchell F Brin; N Risch; H Shale; Robert E Burke; Paul Greene; Stanley Fahn
Inheritance of idiopathic torsion dystonia among Ashkenazi Jews.
Advances in neurology 1988;50():45-56.
1988: Stanley Fahn; D T Williams
Psychogenic dystonia.
Advances in neurology 1988;50():431-55.
1988: Un Jung Kang; Robert E Burke; Stanley Fahn
Tardive dystonia.
Advances in neurology 1988;50():415-29.
1988: Susan Bressman; Stanley Fahn; Robert E Burke
Paroxysmal non-kinesigenic dystonia.
Advances in neurology 1988;50():403-13.
1988: J N Rutledge; S K Hilal; A J Silver; R Defendini; Stanley Fahn
Magnetic resonance imaging of dystonic states.
Advances in neurology 1988;50():265-75.
1988: M Ruberg; A Villageois; Anne-Marie Bonnet; François Rieger; Yves Agid; Stanley Fahn
Acetylcholinesterase and butyrylcholinesterase in cerebrospinal fluid from patients with dystonia.
Advances in neurology 1988;50():211-3.
1988: J G de Yebenes; C Moskowitz; Stanley Fahn; M H Saint-Hilaire
Long-term treatment with levodopa in a family with autosomal dominant torsion dystonia.
Advances in neurology 1988;50():101-11.
1988: Stanley Fahn
Blepharospasm: a form of focal dystonia.
Advances in neurology 1988;49():125-33.
1988: H Shale; Stanley Fahn; Donald B Calne
Case 1, 1988. Head tilt in a young girl associated with neck pain and limitation of neck movement.
Movement disorders : official journal of the Movement Disorder Society 1988;3(4):347-51.
1988: D D Truong; J Garcia De Yebenes; G Pezzoli; Vernice Jackson-Lewis; Stanley Fahn
Glycine involvement in DDT-induced myoclonus.
Movement disorders : official journal of the Movement Disorder Society 1988;3(1):77-87.
1988: J G de Yebenes; Stanley Fahn; Vernice Jackson-Lewis; P Jorge; Maria Angeles Mena; J Reiriz
Continuous intracerebroventricular infusion of dopamine and dopamine agonists through a totally implanted drug delivery system in animal models of Parkinson's disease.
Journal of neural transmission. Supplementum 1988;27():141-60.
1988: D D Truong; Stanley Fahn
Therapeutic trial with glycine in myoclonus.
Movement disorders : official journal of the Movement Disorder Society 1988;3(3):222-32.
1988: P Greene; H Shale; Stanley Fahn
Analysis of open-label trials in torsion dystonia using high dosages of anticholinergics and other drugs.
Movement disorders : official journal of the Movement Disorder Society 1988;3(1):46-60.
1988: D D Truong; Stanley Fahn
An early description of dystonia: translation of Schwalbe's thesis and information on his life.
Advances in neurology 1988;50():651-64.
1988: Stanley Fahn
Concept and classification of dystonia.
Advances in neurology 1988;50():1-8.
1988: J L Cadet; C R Clark; Stanley Fahn
Behavioral effects of alpha-benzyl-N-methylphenethylamine (ABNMP), a methamphetamine analog: inhibition by ketanserin and para-chlorophenylalanine (PCPA).
Pharmacology, biochemistry, and behavior 1988;29(1):125-8.
1988: J G de Yebenes; M F Brin; Maria Angeles Mena; C De Felipe; R M del Rio; E Bazan; A Martinez; Stanley Fahn; J Del Rio; A Vazquez
Neurochemical findings in neuroacanthocytosis.
Movement disorders : official journal of the Movement Disorder Society 1988;3(4):300-12.
1988: Patricia L Kramer; Laurie J Ozelius; Mitchell F Brin; Stanley Fahn; Kenneth K Kidd; James Gusella; X O Breakefield
Molecular genetics of an autosomal dominant form of torsion dystonia.
Advances in neurology 1988;50():57-66.
1988: Eduardo Tolosa; J Kulisevsky; Stanley Fahn
Meige syndrome: primary and secondary forms.
Advances in neurology 1988;50():509-15.
1988: Robert E Burke; Stanley Fahn
An evaluation of sustained postural abnormalities in rats induced by intracerebro-ventricular injection of chlorpromazine methiodide or somatostatin as models of dystonia.
Advances in neurology 1988;50():335-42.
1988: Mitchell F Brin; C Moskowitz; Stanley Fahn
Dystonia clinical research center tissue resource facility: investigations on collected tissue.
Advances in neurology 1988;50():215-22.
1988: Dale J Lange; Mitchell F Brin; Stanley Fahn; R E Lovelace
Distant effects of locally injected botulinum toxin: incidence and course.
Advances in neurology 1988;50():609-13.
1987: J L Cadet; B Kuyatt; Stanley Fahn; E B De Souza
Differential changes in 125I-LSD-labeled 5-HT-2 serotonin receptors in discrete regions of brain in the rat model of persistent dyskinesias induced by iminodipropionitrile (IDPN): evidence from autoradiographic studies.
Brain research 1987;437(2):383-6.
1987: S M Gollomp; Stanley Fahn
Transient dystonia as a complication of varicella.
Journal of neurology, neurosurgery, and psychiatry 1987;50(9):1228-9.
1987: J García de Yébenes; Stanley Fahn
[New therapeutic alternatives in Parkinson disease].
Neurología (Barcelona, Spain) 1987;2(5):199-201.
1987: Stanley Fahn
Systemic therapy of dystonia.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1987;14(3 Suppl):528-32.
1987: J N Rutledge; S K Hilal; A J Silver; R Defendini; Stanley Fahn
Study of movement disorders and brain iron by MR.
AJR. American journal of roentgenology 1987;149(2):365-79.
1987: Dale J Lange; Mitchell F Brin; C L Warner; Stanley Fahn; R E Lovelace
Distant effects of local injection of botulinum toxin.
Muscle & nerve 1987;10(6):552-5.
1987: Stanley Fahn
Drug treatment of hyperkinetic movement disorders.
Seminars in neurology 1987;7(2):192-208.
1987: Patricia L Kramer; Laurie J Ozelius; James Gusella; Stanley Fahn; Kenneth K Kidd; X O Breakefield
Exclusion of autosomal dominant dystonia gene from large regions of chromosomes 11p, 13q, and 21q by multi-point linkage analysis.
Genetic epidemiology 1987;4(5):377-86.
1987: H Shale; Stanley Fahn; William Koller; Anthony E Lang
What is it? Case 1, 1987: unusual tremors, bradykinesia, and cerebral lucencies.
Movement disorders : official journal of the Movement Disorder Society 1987;2(4):321-38.
1987: Mitchell F Brin; Stanley Fahn; C Moskowitz; A Friedman; H M Shale; Paul Greene; Andrew Blitzer; T List; D Lange; R E Lovelace
Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm.
Movement disorders : official journal of the Movement Disorder Society 1987;2(4):237-54.
1987: Stanley Fahn
Paroxysmal myoclonic dystonia with vocalisations.
Journal of neurology, neurosurgery, and psychiatry 1987;50(1):117-8.
1987: J G de Yebenes; Stanley Fahn; Vernice Jackson-Lewis; Maria Angeles Mena
The effect of intracerebroventricular infusion of (+)-4-propyl-9-hydroxynapthoxacine (PHNO) through a totally implanted drug delivery system in rats with dopamine deficiency.
Movement disorders : official journal of the Movement Disorder Society 1987;2(4):291-9.
1987: J G de Yebenes; Stanley Fahn; S Lovelle; Vernice Jackson-Lewis; P Jorge; Maria Angeles Mena; J Reiriz; J C Bustos; C Magariños; A Martinez
Continuous intracerebroventricular infusion of dopamine and dopamine agonists through a totally implanted drug delivery system in animal models of Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1987;2(3):143-58.
1986: Richard Mayeux; Yaakov Stern; A Herman; L Greenbaum; Stanley Fahn
Correlates of early disability in Huntington's disease.
Annals of neurology 1986;20(6):727-31.
1986: Andrew Blitzer; Mitchell F Brin; Stanley Fahn; D Lange; R E Lovelace
Botulinum toxin (BOTOX) for the treatment of "spastic dysphonia" as part of a trial of toxin injections for the treatment of other cranial dystonias.
The Laryngoscope 1986;96(11):1300-1.
1986: M Traub; A Reches; H R Wagner; Stanley Fahn
Reserpine-induced up-regulation of dopamine D2 receptors in the rat striatum is enhanced by denervation but not by chronic receptor blockade.
Neuroscience letters 1986;70(2):245-9.
1986: Wayne Hening; A Walters; N Kavey; S Gidro-Frank; Lucien J Cote; Stanley Fahn
Dyskinesias while awake and periodic movements in sleep in restless legs syndrome: treatment with opioids.
Neurology 1986;36(10):1363-6.
1986: M N Hassan; D Higgins; M Traub; Stanley Fahn
Chronic treatment with bromocriptine induces behavioral supersensitivity in rats.
Life sciences 1986;39(6):513-8.
1986: A Friedman; Stanley Fahn
Spontaneous remissions in spasmodic torticollis.
Neurology 1986;36(3):398-400.
1986: R E Burke; Stanley Fahn; CD Marsden
Torsion dystonia: a double-blind, prospective trial of high-dosage trihexyphenidyl.
Neurology 1986;36(2):160-4.
1986: A Walters; Wayne Hening; Lucien J Cote; Stanley Fahn
Dominantly inherited restless legs with myoclonus and periodic movements of sleep: a syndrome related to the endogenous opiates?
Advances in neurology 1986;43():309-19.
1986: Susan Bressman; Stanley Fahn; M Eisenberg; M Brin; W Maltese
Biotin-responsive encephalopathy with myoclonus, ataxia, and seizures.
Advances in neurology 1986;43():119-25.
1986: Stanley Fahn; CD Marsden; M H Van Woert
Definition and classification of myoclonus.
Advances in neurology 1986;43():1-5.
1986: M N Hassan; A Reches; C Kuhn; D Higgins; Stanley Fahn
Pharmacologic evaluation of dopaminergic receptor blockade by metoclopramide.
Clinical neuropharmacology 1986;9(1):71-8.
1986: Stanley Fahn
Generalized dystonia: concept and treatment.
Clinical neuropharmacology 1986;9 Suppl 2():S37-48.
1986: Robert E Burke; Mitchell F Brin; Stanley Fahn; Susan Bressman; C Moskowitz
Analysis of the clinical course of non-Jewish, autosomal dominant torsion dystonia.
Movement disorders : official journal of the Movement Disorder Society 1986;1(3):163-78.
1986: Stanley Fahn; CD Marsden
The video medium creates new responsibilities and opportunities.
Movement disorders : official journal of the Movement Disorder Society 1986;1(2):91-2.
1986: H Shale; Stanley Fahn; Richard Mayeux
Tics in a patient with Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1986;1(1):79-83.
1986: Joseph Jankovic; Stanley Fahn
The phenomenology of tics.
Movement disorders : official journal of the Movement Disorder Society 1986;1(1):17-26.
1986: Susan Bressman; Stanley Fahn
Essential myoclonus.
Advances in neurology 1986;43():287-94.
1986: Stanley Fahn
Posthypoxic action myoclonus: literature review update.
Advances in neurology 1986;43():157-69.
1986: Un Jung Kang; Robert E Burke; Stanley Fahn
Natural history and treatment of tardive dystonia.
Movement disorders : official journal of the Movement Disorder Society 1986;1(3):193-208.
1986: A Walters; Wayne Hening; Sudhansu Chokroverty; Stanley Fahn
Opioid responsiveness in patients with neuroleptic-induced akathisia.
Movement disorders : official journal of the Movement Disorder Society 1986;1(2):119-27.
1986: H R Wagner; A Reches; E Yablonskaya; Stanley Fahn
Clonazepam-induced up-regulation of serotonin1 and serotonin2 binding sites in rat frontal cortex.
Advances in neurology 1986;43():645-51.
1986: Stanley Fahn
Newer drugs for posthypoxic action myoclonus: observations from a well-studied case.
Advances in neurology 1986;43():197-9.
1985: R E Burke; Stanley Fahn
The effect of selective lesions on vestibular nuclear complex choline acetyltransferase activity in the rat.
Brain research 1985;360(1-2):172-82.
1985: M Traub; H R Wagner; M Hassan; Vernice Jackson-Lewis; Stanley Fahn
The effects of chronic bromocriptine treatment on behaviour and dopamine receptor binding in the rat striatum.
European journal of pharmacology 1985;118(1-2):147-54.
1985: A Reches; H R Wagner; Vernice Jackson-Lewis; Stanley Fahn
Presynaptic inhibition of dopamine synthesis in rat striatum: effects of chronic dopamine depletion and receptor blockade.
Brain research 1985;347(2):346-9.
1985: Stanley Fahn
Lack of benefit from cervical cord stimulation for dystonia.
The New England journal of medicine 1985;313(19):1229.
1985: A Blitzer; R E Lovelace; M F Brin; Stanley Fahn; M E Fink
Electromyographic findings in focal laryngeal dystonia (spastic dysphonia).
The Annals of otology, rhinology, and laryngology 1985;94(6 Pt 1):591-4.
1985: A Reches; Vernice Jackson-Lewis; Stanley Fahn
DL-threo-DOPS as a precursor of noradrenaline.
Naunyn-Schmiedeberg's archives of pharmacology 1985;331(2-3):202-8.
1985: H R Wagner; A Reches; Stanley Fahn
Clonazepam-induced up-regulation of serotonin1 binding sites in frontal cortex of rat.
Neuropharmacology 1985;24(10):953-6.
1985: A Reches; K P Liu; S E Karpiak; Stanley Fahn; T B Cooper; R Suckow; Vernice Jackson-Lewis; H Tamir
Serotonin depletion induced by reserpine is attenuated by prophylactic administration of lithium.
European journal of pharmacology 1985;113(2):225-31.
1985: R E Burke; Stanley Fahn
Pharmacokinetics of trihexyphenidyl after short-term and long-term administration to dystonic patients.
Annals of neurology 1985;18(1):35-40.
1985: R E Burke; Stanley Fahn
Serum trihexyphenidyl levels in the treatment of torsion dystonia.
Neurology 1985;35(7):1066-9.
1985: Stanley Fahn
A therapeutic approach to tardive dyskinesia.
The Journal of clinical psychiatry 1985;46(4 Pt 2):19-24.
1985: R E Burke; Stanley Fahn
Choline acetyltransferase activity of the principal vestibular nuclei of rat, studied by micropunch technique.
Brain research 1985;328(1):196-9.
1985: William Maltese; Susan Bressman; Stanley Fahn; D C De Vivo
Acetylcholinesterase activity in patients with torsion dystonia. Measurement in erythrocyte membranes.
Archives of neurology 1985;42(2):154-5.
1985: R E Burke; A Reches; M M Traub; J Ilson; M Swash; Stanley Fahn
Tetrabenazine induces acute dystonic reactions.
Annals of neurology 1985;17(2):200-2.
1985: Robert E Burke; Stanley Fahn; CD Marsden; Susan Bressman; C Moskowitz; J Friedman
Validity and reliability of a rating scale for the primary torsion dystonias.
Neurology 1985;35(1):73-7.
1985: A I Barkai; S Kowalik; A Reches; T B Cooper; Stanley Fahn
Attenuation by electroshock treatment of the haloperidol-induced rise in the binding of 3H-imipramine to rat brain membranes.
Psychopharmacology 1985;86(4):400-3.
1984: A M Crider; T F Hemdi; M N Hassan; Stanley Fahn
Synthesis and dopaminergic activity of 3-(3,4-dihydroxyphenyl)-1-n-propylpyrrolidine hydrobromide.
Journal of pharmaceutical sciences 1984;73(11):1585-7.
1984: Susan Bressman; Stanley Fahn; Catherine T Falk; F H Allen; N Suciu-Foca
Genetic linkage analysis in primary torsion dystonia.
Neurology 1984;34(11):1490-3.
1984: A Reches; H R Wagner; Vernice Jackson-Lewis; E Yablonskaya-Alter; Stanley Fahn
Chronic levodopa or pergolide administration induces down-regulation of dopamine receptors in denervated striatum.
Neurology 1984;34(9):1208-12.
1984: A Walters; Vernice Jackson-Lewis; Stanley Fahn
Little effect of dimethyl sulfoxide on blood-brain barrier to dopamine.
Experientia 1984;40(8):859-61.
1984: Stanley Fahn; Joseph Jankovic
Practical management of dystonia.
Neurologic clinics 1984;2(3):555-69.
1984: Stanley Fahn
The varied clinical expressions of dystonia.
Neurologic clinics 1984;2(3):541-54.
1984: R J Bodnar; Jeffrey Kordower; A Reches; M M Wallace; Stanley Fahn
Reductions in pain thresholds and morphine analgesia following intracerebroventricular parachlorophenylalanine.
Pharmacology, biochemistry, and behavior 1984;21(1):79-84.
1984: D H Jiang; A Reches; H R Wagner; Stanley Fahn
Biochemical and behavioral evaluation of pergolide as a dopamine agonist in the rat brain.
Neuropharmacology 1984;23(3):295-301.
1984: Stanley Fahn; Susan Bressman
Should levodopa therapy for Parkinsonism be started early or late? Evidence against early treatment.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1984;11(1 Suppl):200-5.
1984: Yaakov Stern; Richard Mayeux; J Ilson; Stanley Fahn; Lucien J Cote
Pergolide therapy for Parkinson's disease: neurobehavioral changes.
Neurology 1984;34(2):201-4.
1984: J Ilson; Stanley Fahn; Lucien J Cote
Painful dystonic spasms in Parkinson's disease.
Advances in neurology 1984;40():395-8.
1984: A Reches; Stanley Fahn
Catechol-O-methyltransferase and Parkinson's disease.
Advances in neurology 1984;40():171-9.
1984: A Reches; H R Wagner; A I Barkai; Vernice Jackson-Lewis; E Yablonskaya-Alter; Stanley Fahn
Electroconvulsive treatment and haloperidol: effects on pre- and postsynaptic dopamine receptors in rat brain.
Psychopharmacology 1984;83(2):155-8.
1984: A Reches; Vernice Jackson-Lewis; Stanley Fahn
Lithium does not interact with haloperidol in the dopaminergic pathways of the rat brain.
Psychopharmacology 1984;82(4):330-4.
1983: R E Burke; Stanley Fahn
Chlorpromazine methiodide acts at the vestibular nuclear complex to induce barrel rotation in the rat.
Brain research 1983;288(1-2):273-81.
1983: R E Burke; Stanley Fahn
Studies of somatostatin-induced barrel rotation in rats.
Regulatory peptides 1983;7(3):207-20.
1983: Stanley Fahn
High dosage anticholinergic therapy in dystonia.
Neurology 1983;33(10):1255-61.
1983: A Reches; R H Wagner; Vernice Jackson-Lewis; E Yablonskaya-Alter; Stanley Fahn
Dopamine receptors in the denervated striatum: further supersensitivity by chronic haloperidol treatment.
Brain research 1983;275(1):183-5.
1983: A Reches; M N Hassan; Vernice Jackson-Lewis; Stanley Fahn
Lithium attenuates dopamine depleting effects of reserpine and tetrabenazine but not that of alpha methyl-p-tyrosine.
Life sciences 1983;33(2):157-60.
1983: A Reches; Stanley Fahn
Lithium in the "on-off" phenomenon.
Annals of neurology 1983;14(1):91-2.
1983: A Reches; R E Burke; C M Kuhn; M N Hassan; Vernice Jackson-Lewis; Stanley Fahn
Tetrabenazine, an amine-depleting drug, also blocks dopamine receptors in rat brain.
The Journal of pharmacology and experimental therapeutics 1983;225(3):515-21.
1983: A Reches; M N Hassan; Vernice Jackson-Lewis; Stanley Fahn
Lithium interferes with reserpine-induced dopamine depletion.
Annals of neurology 1983;13(6):671-3.
1983: D Jiang; A Reches; Stanley Fahn
Normal erythrocyte uptake of L-DOPA in Parkinson's, Huntington's, and related diseases.
Neurology 1983;33(6):793-6.
1983: Stanley Fahn
Treatment of tardive dyskinesia: use of dopamine-depleting agents.
Clinical neuropharmacology 1983;6(2):151-8.
1983: R E Burke; Stanley Fahn
Electroencephalographic studies of chlorpromazine methiodide and somatostatin-induced barrel rotation in rats.
Experimental neurology 1983;79(3):704-13.
1983: A Reches; R E Burke; D Jiang; H R Wagner; Stanley Fahn
Neurotensin interacts with dopaminergic neurons in rat brain.
Peptides 1983;4(1):43-8.
1983: J Ilson; Stanley Fahn; Richard Mayeux; Lucien J Cote; S R Snider
Pergolide treatment in parkinsonism.
Advances in neurology 1983;37():85-94.
1983: Stanley Fahn
Long-term treatment of tardive dyskinesia with presynaptically acting dopamine-depleting agents.
Advances in neurology 1983;37():267-76.
1983: R E Burke; Stanley Fahn
Double-blind evaluation of trihexyphenidyl in dystonia.
Advances in neurology 1983;37():189-92.
1983: J Lobo Antunes; Stanley Fahn; Lucien J Cote
Normal pressure hydrocephalus and Parkinson's disease.
Journal of neural transmission. Supplementum 1983;19():225-31.
1983: S M Gollomp; Stanley Fahn; R E Burke; A Reches; J Ilson
Therapeutic trials in Meige syndrome.
Advances in neurology 1983;37():207-13.
1983: Stanley Fahn
High-dosage anticholinergic therapy in dystonia.
Advances in neurology 1983;37():177-88.
1982: Stanley Fahn
Pathophysiological mechanisms of adverse effects from levodopa therapy.
Rinshō shinkeigaku = Clinical neurology 1982;22(12):1088-91.
1982: R E Burke; Stanley Fahn; Joseph Jankovic; CD Marsden; Anthony E Lang; S Gollomp; J Ilson
Tardive dystonia: late-onset and persistent dystonia caused by antipsychotic drugs.
Neurology 1982;32(12):1335-46.
1982: A Reches; D Jiang; Stanley Fahn
Effect of 3',4'-dihydroxy-2-methyl-propriophenone (U-0521) on catechol-O-methyltransferase activity and on DOPA accumulation in rat red blood cells and corpus striatum.
Biochemical pharmacology 1982;31(21):3415-8.
1982: R E Burke; Stanley Fahn; H R Wagner; M Smeal
Chlorpromazine methiodide-induced barrel rotation: an antimuscarinic effect.
Brain research 1982;250(1):133-42.
1982: Richard Mayeux; Stanley Fahn
Paroxysmal dystonic choreoathetosis in a patient with familial ataxia.
Neurology 1982;32(10):1184-6.
1982: A Reches; Stanley Fahn
3-O-methyldopa blocks dopa metabolism in rat corpus striatum.
Annals of neurology 1982;12(3):267-71.
1982: A Reches; H R Wagner; Vernice Jackson-Lewis; Stanley Fahn
Chronic lithium administration has no effect on haloperidol-induced supersensitivity of pre- and postsynaptic dopamine receptors in rat brain.
Brain research 1982;246(1):172-7.
1982: A Reches; L R Mielke; Stanley Fahn
3-o-methyldopa inhibits rotations induced by levodopa in rats after unilateral destruction of the nigrostriatal pathway.
Neurology 1982;32(8):887-8.
1982: A Reches; H R Wagner; D Jiang; Vernice Jackson-Lewis; Stanley Fahn
The effect of chronic L-dopa administration on supersensitive pre- and postsynaptic dopaminergic receptors in rat brain.
Life sciences 1982;31(1):37-44.
1982: A Reches; D Jiang; Stanley Fahn
Catechol-O-methyltransferase inhibition by U-0521 increases striatal utilization of levodopa.
Naunyn-Schmiedeberg's archives of pharmacology 1982;320(1):34-7.
1982: R E Burke; Stanley Fahn; Joseph Jankovic; CD Marsden; Anthony E Lang; S Gollomp; J Ilson
Tardive dystonia and inappropriate use of neuroleptic drugs.
Lancet 1982;1(8284):1299.
1982: A Reches; Stanley Fahn; J Bhawan
Chronic dopa feeding of mice.
Neurology 1982;32(6):684-5.
1982: A L Prasad; Stanley Fahn
A semiautomated method for the rapid determination of dopa: comparison of plasma and erythrocyte-dopa concentration in levodopa-treated patients.
Biochemical medicine 1982;27(3):297-304.
1982: R Matison; Richard Mayeux; J Rosen; Stanley Fahn
"Tip-of-the-tongue" phenomenon in Parkinson disease.
Neurology 1982;32(5):567-70.
1982: Stanley Fahn
A case of post-traumatic tic syndrome.
Advances in neurology 1982;35():349-50.
1982: Stanley Fahn
The clinical spectrum of motor tics.
Advances in neurology 1982;35():341-4.
1981: R E Burke; Stanley Fahn; Richard Mayeux; H Weinberg; K Louis; J H Willner
Neuroleptic malignant syndrome caused by dopamine-depleting drugs in a patient with Huntington disease.
Neurology 1981;31(8):1022-5.
1981: A Floud; Stanley Fahn
L-DOPA (L-3,4-dihydroxyphenylalanine) uptake by human red blood cells.
Biochimica et biophysica acta 1981;645(2):165-9.
1980: Stanley Fahn
Levodopa provocative test for Huntington's disease.
The New England journal of medicine 1980;303(15):884.
1980: R E Burke; Stanley Fahn; A P Gold
Delayed-onset dystonia in patients with "static" encephalopathy.
Journal of neurology, neurosurgery, and psychiatry 1980;43(9):789-97.
1980: Joseph Jankovic; Stanley Fahn
Physiologic and pathologic tremors. Diagnosis, mechanism, and management.
Annals of internal medicine 1980;93(3):460-5.
1980: Richard Mayeux; S Hunter; Stanley Fahn
More on myoclonus in Alzheimer disease.
Annals of neurology 1980;8(2):200.
1980: Stanley Fahn; Lucien J Cote; R E Barrett; S R Snider
Further experiences with low doses of bromocriptine in Parkinson's disease.
Advances in biochemical psychopharmacology 1980;23():255-60.
1980: Stanley Fahn; Richard Mayeux
Unilateral Parkinson's disease and contralateral tardive dyskinesia: a unique case with successful therapy that may explain the pathophysiology of these two disorders.
Journal of neural transmission. Supplementum 1980;(16):179-85.
1979: Ronald P Lesser; Stanley Fahn; S R Snider; Lucien J Cote; W P Isgreen; R E Barrett
Analysis of the clinical problems in parkinsonism and the complications of long-term levodopa therapy.
Neurology 1979;29(9 Pt 1):1253-60.
1979: Stanley Fahn; Lucien J Cote; S R Snider; R E Barrett; W P Isgreen
The role of bromocriptine in the treatment of parkinsonism.
Neurology 1979;29(8):1077-83.
1979: Stanley Fahn; R Comi; S R Snider; A L Prasad
Effect of a catechol-O-methyl transferase inhibitor, U-0521, with levodopa administration.
Biochemical pharmacology 1979;28(7):1221-5.
1979: D V Forrest; Stanley Fahn
Tardive dysphrenia and subjective akathisia.
The Journal of clinical psychiatry 1979;40(4):206.
1979: Stanley Fahn; A Barbeau; Donald B Calne; RC Duvoisin; C Markham; G Paulson
Symposium I: Therapeutic controversies in movement disorders.
Transactions of the American Neurological Association 1979;104():31-51.
1979: J N Sharma; S R Snider; Stanley Fahn; E Hiesiger
Anoxic myoclonus in the rat.
Advances in neurology 1979;26():181-9.
1979: K Tellerman; A Astrow; Stanley Fahn; S R Snider; R S Snider; J M Glassgold
Cerebellar control of catecholaminergic activities implications for drug therapy of movement disorders.
International journal of neurology 1979;13(1-4):135-55.
1979: Stanley Fahn
Posthypoxic action myoclonus: review of the literature and report of two new cases with response to valproate and estrogen.
Advances in neurology 1979;26():49-84.
1979: Ira Shoulson; Stanley Fahn
Huntington disease: clinical care and evaluation.
Neurology 1979;29(1):1-3.
1978: Stanley Fahn
Post-anoxic action myoclonus: improvement with valproic acid.
The New England journal of medicine 1978;299(6):313-4.
1978: Stanley Fahn
Tardive dyskinesia may be only akathisia.
The New England journal of medicine 1978;299(4):202-3.
1978: Richard Mayeux; Stanley Fahn
Strokes and ulcerative colitis.
Neurology 1978;28(6):571-4.
1978: Ronald P Lesser; Stanley Fahn
Dystonia: a disorder often misdiagnosed as a conversion reaction.
The American journal of psychiatry 1978;135(3):349-52.
1978: Stanley Fahn
Treatment of tardive dyskinesia with combined reserpine and alpha-methyltyrosine.
Transactions of the American Neurological Association 1978;103():100-3.
1978: Stanley Fahn; Donald B Calne
Considerations in the management of parkinsonism.
Neurology 1978;28(1):5-7.
1977: William G Johnson; Stanley Fahn
Treatment of vascular hemiballism and hemichorea.
Neurology 1977;27(7):634-6.
1977: C S Hutt; S R Snider; Stanley Fahn
Interaction between bromocriptine and levodopa. Biochemical basis for an improved treatment for parkinsonism.
Neurology 1977;27(6):503-10.
1977: S R Snider; D Sahar; A L Prasad; Stanley Fahn
Changes in adrenal dopamine concentration after metyrapone or ACTH administration: implications for the in vivo regulation of dopamine beta-hydroxylase by glucocorticoids.
Life sciences 1977;20(6):1077-85.
1977: S R Snider; C Miller; A L Prasad; Vernice Jackson-Lewis; Stanley Fahn
Is dopamine a neurohormone of the adrenal medulla? Studies with morphine stimulation.
Naunyn-Schmiedeberg's archives of pharmacology 1977;297(1):17-22.
1977: Stanley Fahn
New approaches in the management of hyperkinetic movement disorders.
Advances in experimental medicine and biology 1977;90():157-73.
1976: S R Snider; C Hutt; B Stein; A L Prasad; Stanley Fahn
Correlation of behavioural inhibition or excitation produced by bromocriptine with changes in brain catecholamine turnover.
The Journal of pharmacy and pharmacology 1976;28(7):563-6.
1976: S R Snider; Stanley Fahn; W P Isgreen; Lucien J Cote
Primary sensory symptoms in parkinsonism.
Neurology 1976;26(5):423-9.
1976: Stanley Fahn; Lucien J Cote
Stability of enzymes in post-mortem rat brain.
Journal of neurochemistry 1976;26(5):1039-42.
1976: W P Isgreen; A M Chutorian; Stanley Fahn
Sequential parkinsonism and chorea following "mild" inluenza.
Transactions of the American Neurological Association 1976;101():56-60.
1976: W P Isgreen; Stanley Fahn; R E Barrett; S R Snider; A M Chutorian
Carbamazepine in torsion in dystonia.
Advances in neurology 1976;14():411-6.
1976: Stanley Fahn; R Eldridge
Definition of dystonia and classification of the dystonic states.
Advances in neurology 1976;14():1-5.
1976: Stanley Fahn
Biochemistry of the basal ganglia.
Advances in neurology 1976;14():59-89.
1975: A L Prasad; Stanley Fahn; W P Isgreen
Dopamine: a sensitive automated assay and examples of levodopa therapy.
Biochemical medicine 1975;14(1):24-32.
1975: Stanley Fahn; S Snider; A L Prasad; E Lane; H Makadon
Normalization of brain serotonin by L-tryptophan in levodopa-treated rats.
Neurology 1975;25(9):861-5.
1975: Stanley Fahn; W P Isgreen
Long-term evaluation of amantadine and levodopa combination in parkinsonism by double-blind corssover analyses.
Neurology 1975;25(8):695-700.
1975: S R Snider; Stanley Fahn; Lucien J Cote; W P Isgreen
Letter: Pain, paresthesia and parkinsonism.
The New England journal of medicine 1975;293(4):200.
1974: L Prockop; Stanley Fahn; P Barbour
Homovanillic acid: entry rate kinetics for transfer from plasma to cerebrospinal fluid.
Brain research 1974;80(3):435-42.
1974: M P Earnest; Stanley Fahn; J H Karp; L P Rowland
Normal pressure hydrocephalus and hypertensive cerebrovascular disease.
Archives of neurology 1974;31(4):262-6.
1974: Stanley Fahn
"On-off" phenomenon with levodopa therapy in Parkinsonism. Clinical and pharmacologic correlations and the effect of intramuscular pyridoxine.
Neurology 1974;24(5):431-41.
1974: A L Prasad; Stanley Fahn
3-O-methyl metabolites of catecholamines: automated fluorometric assay and their plasma levels in patients receiving levodopa and carbidopa.
Biochemical medicine 1974;9(2):136-47.
1974: W G Johnson; Stanley Fahn
Treatment of vascular hemichorea and hemiballismus with perphenazine.
Transactions of the American Neurological Association 1974;99():222-4.
1974: D G Cook; Stanley Fahn; K A Brait
Chronic manganese intoxication.
Archives of neurology 1974;30(1):59-64.
1973: A L Prasad; Stanley Fahn
Fluorometric determination of homovanillic acid in the presence of other acid metabolites of catecholamines.
Journal of neurochemistry 1973;21(6):1551-4.
1973: K Brait; Stanley Fahn; G A Schwarz
Sporadic and familial parkinsonism and motor neuron disease.
Neurology 1973;23(9):990-1002.
1972: Stanley Fahn
Differential diagnosis of tremors.
The Medical clinics of North America 1972;56(6):1363-75.
1972: Stanley Fahn
Treatment of choreic movements with perphenazine.
Diseases of the nervous system 1972;33(10):653-8.
1972: Stanley Fahn
L-dopa effect in Huntington's chorea.
The New England journal of medicine 1972;287(9):467-8.
1972: Stanley Fahn; A L Prasad; R Delesie
A reliable and simple method for simultaneous determination of DOPA and 3-O-methyldopa in plasma and brain.
Analytical biochemistry 1972;46(2):557-75.
1971: Stanley Fahn; L R Libsch; R W Cutler
Monoamines in the human neostriatum: topographic distribution in normals and in Parkinson's disease and their role in akinesia, rigidity, chorea, and tremor.
Journal of the neurological sciences 1971;14(4):427-55.
1971: Stanley Fahn; G Craddock; G Kumin
Acute toxic psychosis from suicidal overdosage of amantadine.
Archives of neurology 1971;25(1):45-8.
1971: J N DiGiacomo; Stanley Fahn; J B Glass; R J Westlake
A case with Gilles de la Tourette's syndrome: recurrent refractoriness to haloperidol, and unsuccessful treatment with L-dopa.
The Journal of nervous and mental disease 1971;152(2):115-7.
1971: C P O'Brien; J N DiGiacomo; Stanley Fahn; G A Schwarz
Mental effects of high-dosage levodopa.
Archives of general psychiatry 1971;24(1):61-4.
1970: G A Schwarz; Stanley Fahn
Newer medical treatment in parkinsonism.
The Medical clinics of North America 1970;54(3):773-85.
1969: Stanley Fahn; J S Rodman; Lucien J Cote
Association of tyrosine hydroxylase with synaptic vesicles in bovine caudate nucleus.
Journal of neurochemistry 1969;16(9):1293-300.
1968: Stanley Fahn
Correlation of sodium-potassium-activated adenosine triphosphatase with acetyl cholinesterase of the Electrophorus electric organ.
Experientia 1968;24(6):544-5.
1968: Stanley Fahn; Lucien J Cote
Regional distribution of sodium-potassium activated adenosine triphosphatase in the brain of the Rhesus monkey.
Journal of neurochemistry 1968;15(5):433-6.
1968: Stanley Fahn; G J Koval; R W Albers
Sodium-potassium-activated adenosine triphosphatase of Electrophorus electric organ. V. Phosphorylation by adenosine triphosphate-32P.
The Journal of biological chemistry 1968;243(8):1993-2002.
1968: Stanley Fahn; Lucien J Cote
Regional and subcellular distribution of tyrosine hydroxylase.
Neurology 1968;18(3):293-4.
1968: Stanley Fahn; Lucien J Cote
Regional distribution of gamma-aminobutyric acid (GABA) in brain of the rhesus monkey.
Journal of neurochemistry 1968;15(3):209-13.
1968: Stanley Fahn; Lucien J Cote
Regional distribution of choline acetylase in the brain of the rhesus monkey.
Brain research 1968;7(2):323-5.
1966: Stanley Fahn; M R Hurley; G J Koval; R W Albers
Sodium-potassium-activated adenosine triphosphatase of Electrophorus electric organ. II. Effects of N-ethylmaleimide and other sulfhydryl reagents.
The Journal of biological chemistry 1966;241(8):1890-5.
1966: Stanley Fahn; G J Koval; R W Albers
Sodium-potassium-activated adenosine triphosphatase of Electrophorus electric organ. I. An associated sodium-activated transphosphorylation.
The Journal of biological chemistry 1966;241(8):1882-9.
1964: Stanley Fahn; R W ALBERS; G J KOVAL
ELECTROPHORUS ADENOSINE TRIPHOSPHATASE: SODIUM-ACTIVATED EXCHANGE AFTER N-ETHYLALEIMIDE TREATMENT.
Science (New York, N.Y.) 1964;145(3629):283-4.
1964: L P ROWLAND; Stanley Fahn; E HIRSCHBERG; D H HARTER
MYOGLOBINURIA.
Archives of neurology 1964;10():537-62.
1963: L P ROWLAND; Stanley Fahn; D L SCHOTLAND
MCARDLE'S DISEASE. HEREDITARY MYOPATHY DUE TO ABSENCE OF MUSCLE PHOSPHORYLASE.
Archives of neurology 1963;9():325-42.
1963: R W ALBERS; Stanley Fahn; G J KOVAL
THE ROLE OF SODIUM IONS IN THE ACTIVATION OF ELECTROPHORUS ELECTRIC ORGAN ADENOSINE TRIPHOSPHATASE.
Proceedings of the National Academy of Sciences of the United States of America 1963;50():474-81.
1963: Stanley Fahn; D L SCHOTLAND; L P ROWLAND
MCARDLE'S DISEASE: HEREDITARY MYOPATHY DUE TO ABSENCE OF MUSCLE PHOSPHORYLASE.
Transactions of the American Neurological Association 1963;88():145-7.